<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Autonomic Nervous System - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">79</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 3330,
    "choices": [
      {
        "id": 13299,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fesoterodine</span></span></p>"
      },
      {
        "id": 13300,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trospium</span></span></p>"
      },
      {
        "id": 13301,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirabegron</span></span></p>"
      },
      {
        "id": 13302,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxybutynin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the new &beta;3 agonist approved for overactive bladder? </span></span></span></p>",
    "unique_key": "Q6496142",
    "question_audio": null,
    "question_video": null,
    "map_id": 35867,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mirabegron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron</strong> is a<strong> &beta;3-adrenoceptor agonist </strong>which is a<strong> newer class of drug</strong> used to <strong>treat overactive bladder.</strong> It works by <strong>relaxing the</strong> <strong>smooth muscle of the bladder</strong>, thereby<strong> increasing bladder capacity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fesoterodine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, it is an<strong> antimuscarinic agent </strong>used for <strong>overactive bladder</strong> but <strong>not a &beta;3 agonist. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Trospium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, also an <strong>antimuscarinic</strong>,<strong> not a &beta;3 agonist</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oxybutynin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> this is an<strong> older antimuscarinic drug </strong>used for <strong>overactive bladder</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron </strong>is the <strong>first &beta;3 agonist</strong> approved for the treatment of <strong>overactive bladder,</strong> offering a <strong>mechanism of action different </strong>from <strong>antimuscarinic agents, </strong>and can be an option for patients who <strong>cannot tolerate </strong>or <strong>do not respond to anticholinergic medications.</strong></span></span></span></p>",
    "correct_choice_id": 13301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3635,
    "choices": [
      {
        "id": 14519,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertensive emergencies</span></span></span></p>"
      },
      {
        "id": 14520,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congestive heart failure</span></span></span></p>"
      },
      {
        "id": 14521,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine prophylaxis</span></span></span></p>"
      },
      {
        "id": 14522,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyarrhythmias</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fenoldopam is used in the management of? </span></span></p>",
    "unique_key": "Q1820733",
    "question_audio": null,
    "question_video": null,
    "map_id": 35872,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Hypertensive emergencies </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fenoldopam </strong>is used in the management of <strong>hypertensive emergencies.</strong> It is a <strong>selective dopamine D1 receptor agonist</strong> that induces <strong>vasodilation of peripheral arterie</strong>s, leading to a <strong>rapid decrease in blood press</strong>ure. One of the advantages of <strong>fenoldopam is its ability</strong> to<strong> enhance renal perfusion</strong>, which is beneficial in<strong> hypertensive emergencies</strong> where<strong> kidney function </strong>may be <strong>compromised.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Congestive heart failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fenoldopam </strong>is <strong>not </strong>typically used in the management of<strong> congestive heart failure (CHF). </strong>Drugs commonly used in <strong>CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists</strong>, which work by different mechanisms to <strong>reduce the workload on the heart </strong>and <strong>improve cardiac output</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Migraine prophylaxis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Fenoldopam </strong>is <strong>not </strong>used for <strong>migraine prophylaxis</strong>. Medications for migraine prevention include <strong>beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs</strong>, which have different mechanisms of action aimed at <strong>reducing the frequency and severity of migraine attacks</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tachyarrhythmias:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fenoldopam </strong>is<strong> not </strong>indicated for the treatment of <strong>tachyarrhythmias. Drugs used </strong>to manage tachyarrhythmias include <strong>beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin</strong>, depending on the<strong> type and cause of the arrhythmia. </strong>These medications work by<strong> modulating cardiac electrical activity </strong>to <strong>normalize heart rhythm</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>specific indications for fenoldopam, </strong>particularly its role in <strong>managing hypertensive emergencies </strong>due to <strong>its vasodilatory effects </strong>and positive impact on <strong>renal perfusion</strong>. Additionally, recognizing that <strong>fenoldopam is not </strong>indicated for<strong> congestive heart failure, migraine prophylaxis, or tachyarrhythmias </strong>underscores the importance of selecting appropriate medications based on the clinical condition being treated.</span></span></p>",
    "correct_choice_id": 14519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3303,
    "choices": [
      {
        "id": 13191,
        "text": "<p><span style=\"font-size:12pt;\">Angle closure glaucoma</span></p>"
      },
      {
        "id": 13192,
        "text": "<p><span style=\"font-size:12pt;\">Asthma</span></p>"
      },
      {
        "id": 13193,
        "text": "<p><span style=\"font-size:12pt;\">Peptic ulcer</span></p>"
      },
      {
        "id": 13194,
        "text": "<p><span style=\"font-size:12pt;\">Urinary incontinence</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">All of the following are indications of antimuscarinic&nbsp;</span><span style=\"font-size:12.0pt;\">drugs except</span><span style=\"color:black;font-size:12.0pt;\">?</span></p>",
    "unique_key": "Q5284000",
    "question_audio": null,
    "question_video": null,
    "map_id": 35878,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Angle closure glaucoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Antimuscarinic drugs</strong> are typically used for their <strong>inhibitory action </strong>on the <strong>parasympathetic nervous system</strong>. They can <strong>relax smooth</strong> <strong>muscle</strong>,<strong> reduce body secretions</strong>, and <strong>decrease gastrointestinal motility, </strong>among other effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Angle closure glaucoma </strong>is a<strong> contraindication </strong>for<strong> antimuscarinic drugs </strong>because these medications can further<strong> narrow or close </strong>the already compromised <strong>drainage angles of the eye, </strong>worsening the condition.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Asthma:</strong>&nbsp;<strong>Antimuscarinics </strong>are <strong>used </strong>to relieve<strong> bronchospasm </strong>by <strong>inhibiting constrictive parasympathetic </strong>influences on the <strong>bronchial smooth muscle.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Peptic ulcer:</strong>&nbsp; These drugs <strong>reduce gastric acid secretion </strong>and are used to <strong>treat peptic ulcers.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Urinary incontinence:</strong>&nbsp; <strong>Antimuscarinics</strong> can <strong>relax the bladder, </strong>reducing the <strong>urgency and frequency of urination </strong>in overactive bladder<strong>.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the treatment of various conditions where <strong>parasympathetic inhibition </strong>is <strong>beneficial, antimuscarinic drugs </strong>are indicated; however, they are<strong> contraindicated in angle-closure glaucoma </strong>due to the risk of <strong>exacerbating the condition</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121431.jpg\" alt=\"\" width=\"1000\" height=\"502\"></span></p>",
    "correct_choice_id": 13191,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3308,
    "choices": [
      {
        "id": 13211,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in heart rate</span></span></p>"
      },
      {
        "id": 13212,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in heart rate</span></span></p>"
      },
      {
        "id": 13213,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in mean arterial pressure</span></span></p>"
      },
      {
        "id": 13214,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased renal perfusion and reduced urine output</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?</span></span></p>",
    "unique_key": "Q5168986",
    "question_audio": null,
    "question_video": null,
    "map_id": 35881,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Increase in mean arterial pressure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the treatment of<strong> septic shock</strong>, the primary therapeutic goal is to <strong>stabilize hemodynamics </strong>and <strong>improve tissue perfusion</strong>. <strong>Nor-epinephrine (norepinephrine) </strong>is a<strong> potent vasopressor </strong>that <strong>increases both systolic and diastolic blood pressure</strong>. It is commonly used to<strong> counteract the vasodilatory effects of septic shock </strong>and help maintain <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increase in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Not the best indicator </strong>for the efficacy of<strong> nor-epinephrine in septic shock</strong>, as the drug may actually lead to a <strong>reflex bradycardia due to increased blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decrease in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - While <strong>nor-epinephrine </strong>can cause a<strong> reflex decrease in heart rate </strong>due to <strong>increased blood pressure, </strong>it&#39;s<strong> not the primary indicator </strong>of therapeutic response in septic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Decreased renal perfusion and reduced urine output</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - These are<strong> potential adverse effects of nor-epinephrine </strong>due to its <strong>vasoconstrictive action</strong>, <strong>not </strong>indicators of a <strong>positive therapeutic response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effectiveness of <strong>nor-epinephrine </strong>in the management of<strong> septic shock </strong>is best<strong> monitored </strong>by an <strong>increase in mean arterial pressure</strong>, aiming to <strong>maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg </strong>to ensure <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harrison 19<sup>th</sup>/1761</span></strong></span></span></p>",
    "correct_choice_id": 13213,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 3284,
    "choices": [
      {
        "id": 13115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed angle glaucoma</span></span></span></p>"
      },
      {
        "id": 13116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
      },
      {
        "id": 13117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cobra bite</span></span></span></p>"
      },
      {
        "id": 13118,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinomimetic drugs can be used for the treatment of all the following conditions except ?</span></span></span></p>",
    "unique_key": "Q6571315",
    "question_audio": null,
    "question_video": null,
    "map_id": 35874,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bradycardia&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs</strong>, which <strong>mimic the action of acetylcholine</strong>, will actually cause<strong> bradycardia </strong>as an <strong>adverse effect </strong>due to their stimulation of <strong>muscarinic receptors in the heart</strong>. Therefore, they are<strong> not used to treat bradycardia</strong>, where the goal is to<strong> increase heart rate</strong>, not decrease it further.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Correct Usage - Closed angle glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is treated with drugs like <strong>Physostigmine and Pilocarpine to increase aqueous humor outflow</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Correct Usage - For a cobra bite:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Neostigmine plus atropine </strong>is used to <strong>counteract the neuromuscular blockade </strong>caused by the <strong>venom</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Correct Usage - In Myasthenia gravis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> drugs such as<strong> Neostigmine </strong>are used to enhance<strong> neuromuscular transmission </strong>by preventing the <strong>breakdown of acetylcholine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Uses of Cholinergic Drugs:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alzheimer&rsquo;s disease </strong>treatment with<strong> Donepezil, Rivastigmine, and Galantamine </strong>to <strong>increase acetylcholine </strong>in the brain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of <strong>xerostomia </strong>with drugs like <strong>Cevimeline </strong>to stimulate <strong>salivary gland secretion</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postoperative urinary retention </strong>and <strong>paralytic ileus </strong>managed with drugs like <strong>Bethanechol and Neostigmine </strong>to stimulate the<strong> bladder detrusor muscle and GI motility</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antidote for anticholinergic poisoning </strong>with<strong> Physostigmine </strong>to counteract <strong>muscarinic receptor blockade.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs </strong>are <strong>not used </strong>for the treatment of<strong> bradycardia </strong>due to their potential to cause a<strong> decrease in heart rate</strong>. They are, however, useful in treating various other conditions where <strong>increased cholinergic action </strong>is beneficial, such as<strong> closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimer&rsquo;s disease.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120058.jpg\" style=\"height:425px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 13116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3306,
    "choices": [
      {
        "id": 13203,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></span></p>"
      },
      {
        "id": 13204,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 1 ml of 1:10000 by intravenous route</span></span></p>"
      },
      {
        "id": 13205,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine 3 mg intravenously</span></span></p>"
      },
      {
        "id": 13206,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine 12 mg intravenously</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of choice for anaphylactic shock is</span></span></p>",
    "unique_key": "Q8792050",
    "question_audio": null,
    "question_video": null,
    "map_id": 35880,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline</strong> is the treatment of choice for <strong>anaphylactic shock</strong> due to its <strong>rapid onset of action </strong>and its effects on<strong> both alpha and beta-adrenergic receptors</strong>. It reverses the symptoms of <strong>anaphylaxis by causing peripheral vasoconstriction, bronchodilation, increasing cardiac output</strong>, and<strong> preventing </strong>further release of <strong>mediators </strong>from <strong>mast cells and basophils</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Adrenaline 1 ml of 1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:10000 by intravenous route:</strong>&nbsp;This is<strong> less </strong>preferred initially due to the <strong>risk of adverse effects </strong>with <strong>intravenous administration</strong> unless <strong>absolutely necessary and under close monitoring. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Atropine 3 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Not used in anaphylaxis</strong>, as it does not address the pathophysiological changes involved in anaphylactic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Adenosine 12 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Not indicated for anaphylaxis </strong>as it&#39;s primarily<strong> used for </strong>certain types of <strong>supraventricular tachycardias.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For<strong> anaphylactic shock</strong>, <strong>adrenaline </strong>is administered <strong>intramuscularly in a 1:1000 concentration as the first-line treatment</strong>. This route is preferred over <strong>subcutaneous or intravenous administration </strong>due to its<strong> effectiveness and safety profile</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harrison 19<sup>th</sup>/2117</span></span></strong></p>",
    "correct_choice_id": 13203,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3346,
    "choices": [
      {
        "id": 13363,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></p>"
      },
      {
        "id": 13364,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol</span></span></p>"
      },
      {
        "id": 13365,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxprenolol</span></span></p>"
      },
      {
        "id": 13366,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are non-selective &beta;-blockers except:</span></span></span></p>",
    "unique_key": "Q1609447",
    "question_audio": null,
    "question_video": null,
    "map_id": 35870,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Betaxolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given options, <strong>Betaxolol</strong> is the <strong>beta-blocker</strong> that is <strong>cardioselective</strong>, meaning it <strong>primarily blocks</strong> <strong>beta-1 adrenergic</strong> <strong>receptors</strong> that are<strong> predominantly</strong> found in the <strong>heart</strong>. This selectivity can <strong>reduce </strong>the risk of <strong>bronchoconstriction</strong> and other side effects <strong>related to beta-2 receptor blockade.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardioselective beta-blockers,</strong> sometimes called <strong>beta-1 selective blockers</strong>, are preferred for patients with <strong>asthma or chronic</strong> <strong>obstructive pulmonary disease (COPD) </strong>as they are<strong> less likely </strong>to cause <strong>constriction of the airways</strong>, which is mediated through <strong>beta-2</strong> <strong>receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carvedilol:</strong> A <strong>non-selective beta-blocker</strong> that also has <strong>alpha-blocking activity, </strong>used for the treatment of <strong>high blood</strong> p<strong>ressure and heart failure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxprenolol:</strong> A <strong>non-selective beta-blocker </strong>with <strong>intrinsic sympathomimetic activity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Labetalol:</strong> A <strong>non-selective beta-blocker </strong>that also <strong>blocks alpha-1 receptors </strong>and is commonly used in<strong> pregnancy-induced</strong> <strong>hypertension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betaxolol </strong>is a <strong>cardioselective beta-blocker</strong> that selectively <strong>blocks beta-1 adrenergic receptors in the heart</strong>, while<strong> Carvedilol,</strong> <strong>Oxprenolol, and Labetalol</strong> are <strong>non-selective beta-blockers </strong>affecting <strong>both</strong> <strong>beta-1 and beta-2 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardio-selective beta blockers:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/33.jpg\" style=\"height:325px; width:300px\" /></span></strong></span></span></p>",
    "correct_choice_id": 13364,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3290,
    "choices": [
      {
        "id": 13139,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tremors</span></span></span></p>"
      },
      {
        "id": 13140,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></p>"
      },
      {
        "id": 13141,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
      },
      {
        "id": 13142,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?</span></span></span></p>",
    "unique_key": "Q9268135",
    "question_audio": null,
    "question_video": null,
    "map_id": 35876,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hypoglycemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;&beta;2 agonists</strong>, like <strong>formoterol</strong>, used as <strong>inhaled bronchodilators </strong>for the management of<strong> bronchial asthma</strong>, can cause a variety of<strong> side effects. Tremors</strong> are a common dose-related side effect due to the stimulation of<strong> &beta;2 receptors in skeletal muscle. Hypokalemia </strong>can occur with the use of<strong> &beta;2 agonists </strong>as they <strong>promote </strong>the <strong>uptake of potassium into cells</strong>, <strong>lowering the potassium concentration</strong> in the <strong>bloodstream</strong>.<strong> Bronchodilation </strong>is the intended therapeutic effect of<strong> &beta;2 agonists</strong>, resulting from the <strong>relaxation of bronchial smooth muscle</strong>. However,<strong> &beta;2 agonists do not </strong>typically cause <strong>hypoglycemia; </strong>in fact, they may <strong>increase blood glucose </strong>levels by<strong> stimulating glycogenolysis and gluconeogenesis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors </strong>- A known <strong>side effect </strong>due to the stimulation of<strong> &beta;2 receptors by &beta;2 agonists. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypokalemia </strong>- Can occur as <strong>&beta;2 agonists </strong>increase<strong> intracellular potassium uptake</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Bronchodilation </strong>- The primary therapeutic action of<strong> formoterol in bronchial asthma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Formoterol, a &beta;2 agonist, does not </strong>cause <strong>hypoglycemia</strong>. Instead, it can cause side effects such as<strong> tremors, hypokalemia </strong>due to <strong>increased potassium uptake into cells</strong>, and the desired effect of <strong>bronchodilation </strong>for the management of<strong> asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "correct_choice_id": 13140,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3276,
    "choices": [
      {
        "id": 13083,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 stimulation by epinephrine following beta 1-stimulation </span></span></span></p>"
      },
      {
        "id": 13084,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of beta-1 receptors following blocking of beta 2 receptors </span></span></span></p>"
      },
      {
        "id": 13085,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of beta-2 receptors following blocking of alpha receptors</span></span></span></p>"
      },
      {
        "id": 13086,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 stimulation by norepinephrine following beta-1 blockade </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an animal model, the phenomenon of vasomotor reversal of Dale can be demonstrated by?</span></span></p>",
    "unique_key": "Q8481934",
    "question_audio": null,
    "question_video": null,
    "map_id": 35873,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stimulation of beta-2 receptors following blocking of alpha receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>phenomenon of vasomotor reversal of Dale</strong> describes a situation where the usual <strong>vasoconstrictive effect of epinephrine</strong> <strong>(adrenaline) </strong>is <strong>reversed to vasodilation.</strong> This can occur if the<strong> alpha-adrenergic receptors</strong>, which typically mediate <strong>vasoconstriction, are blocked. </strong>The remaining action is then through the<strong> beta-adrenergic receptors</strong>, which can cause <strong>vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture2.jpg\" style=\"height:151px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A. Beta-2 stimulation by epinephrine following beta 1-stimulation:</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option <strong>does not </strong>describe <strong>vasomotor reversal of Dale</strong>. <strong>Beta-1 stimulation </strong>typically affects <strong>heart rate and contractility</strong>, not vasomotor responses.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B. Stimulation of beta-1 receptors following blocking of beta 2 receptors:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This also <strong>does not </strong>lead to <strong>vasomotor reversal of Dale</strong>. <strong>Blocking beta-2 receptors </strong>would typically <strong>enhance</strong> the <strong>alpha receptor-mediated vasoconstrictive </strong>effect of <strong>catecholamines, </strong>not reverse it.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C. Stimulation of beta-2 receptors following blocking of alpha receptors:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>correct option </strong>for demonstrating <strong>vasomotor reversal of Dale. </strong>When <strong>alpha receptors are blocked, </strong>the administration of a <strong>catecholamine </strong>will primarily <strong>stimulate the</strong> <strong>beta-2 adrenergic receptors</strong>, leading to <strong>vasodilation,</strong> which is the <strong>opposite</strong> of the usual<strong> vasoconstrictive effect of catecholamines </strong>on <strong>blood vessels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D. Beta-2 stimulation by norepinephrine following beta-1 blockade:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine (noradrenaline) </strong>has a much <strong>weaker effect on beta-2 receptors </strong>compared to <strong>alpha receptors</strong>, so <strong>blocking beta-1 receptors would not </strong>typically result in a <strong>vasomotor reversal. Norepinephrine </strong>is more known for its <strong>strong alpha receptor affinity</strong>, leading to <strong>vasoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> vasomotor reversal of Dale,</strong> characterized by a <strong>switch from vasoconstriction to vasodilation,</strong> is demonstrated by the<strong> stimulation</strong> of <strong>beta-2 receptors</strong> after <strong>alpha receptors have been blocked, </strong>showcasing the <strong>unique and sometimes counterintuitive effect</strong>s that can result from the <strong>complex interplay of the autonomic nervous system&#39;s receptors.</strong></span></span></span></p>",
    "correct_choice_id": 13085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3286,
    "choices": [
      {
        "id": 13123,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric secretion</span></span></span></p>"
      },
      {
        "id": 13124,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuromuscular junction</span></span></span></p>"
      },
      {
        "id": 13125,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sweat glands</span></span></span></p>"
      },
      {
        "id": 13126,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ureteral tone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following? </span></span></span></p>",
    "unique_key": "Q9125545",
    "question_audio": null,
    "question_video": null,
    "map_id": 35875,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Neuromuscular junction </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bethanechol </strong>is a <strong>cholinomimetic agent </strong>that selectively stimulates <strong>muscarinic receptors without </strong>any effect on<strong> nicotinic receptors </strong>such as those found at the<strong> neuromuscular junction (NMJ). Physostigmine, an acetylcholinesterase inhibitor</strong>, <strong>increases levels </strong>of <strong>acetylcholine </strong>at <strong>both muscarinic and nicotinic receptors. </strong>The neuromuscular junction, which <strong>contains nicotinic receptors</strong>, will be affected by <strong>physostigmine </strong>due to <strong>increased acetylcholine</strong> leading to stimulation of these<strong> receptors.</strong> However, <em>bethanechol </em>would <strong>not affect the NMJ </strong>as it <strong>lacks action on nicotinic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Gastric secretion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is mediated by<strong> muscarinic receptors</strong>; thus,<strong> both drugs</strong> would <strong>enhance secretion. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sweat glands:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are also regulated by<strong> muscarinic receptors, </strong>so <strong>both physostigmine and bethanechol </strong>would stimulate <strong>sweating. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ureteral tone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is under the <strong>control of muscarinic receptors, </strong>hence <strong>both drugs </strong>could <strong>increase ureteral tone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Physostigmine</strong> can affect <strong>both muscarinic and nicotinic receptors,</strong> making it effective <strong>at the neuromuscular junction,</strong> while <strong>bethanechol&#39;s</strong> action is limited to <strong>muscarinic receptors</strong> and <strong>does not </strong>influence <strong>neuromuscular transmission.</strong></span></span></span></p>",
    "correct_choice_id": 13124,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3298,
    "choices": [
      {
        "id": 13171,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
      },
      {
        "id": 13172,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha agonist</span></span></span></p>"
      },
      {
        "id": 13173,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></span></p>"
      },
      {
        "id": 13174,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blocker</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male with insulin dependent diabetes having macular edema develops glaucoma. Which of the following anti-glaucoma drugs should be avoided in this patient?&nbsp; </span></span></span></p>",
    "unique_key": "Q7451294",
    "question_audio": null,
    "question_video": null,
    "map_id": 35877,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues,</strong> such as <strong>latanoprost, bimatoprost, and travoprost, </strong>are commonly used to <strong>lower intraocular pressure in</strong> patients with<strong> glaucoma by increasing the outflow of aqueous humor.</strong> However, they have been <strong>associated with</strong> a potential<strong> risk of</strong> <strong>exacerbating macular edema,</strong> particularly in patients with<strong> pre-existing condition</strong>s that predispose them to <strong>retinal edema,</strong> such as <strong>diabetic retinopathy</strong>. In a patient with <strong>insulin-dependent diabetes</strong> and<strong> macular edema,</strong> the use of prostaglandin analogues could potentially worsen the macular edema, thus they should be used with caution or avoided.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Alpha agonist:</strong> Alpha agonists, such as <strong>brimonidine, </strong>work by <strong>decreasing aqueous humor production </strong>and <strong>increasing uveoscleral outflow</strong>. They are <strong>not </strong>specifically<strong> contraindicated in patients </strong>with <strong>diabetic macular edema </strong>and can be used in the management of<strong> glaucoma </strong>in such patients.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Pilocarpine:</strong> Pilocarpine is a <strong>cholinergic agonist </strong>that <strong>works by constricting the pupil </strong>and <strong>pulling the iris away from the trabecular meshwork</strong>, thus <strong>improving the outflow of aqueous humor</strong>. While it is <strong>less commonly</strong> used due to its<strong> side effects</strong> and the <strong>availability of more effective treatments</strong>, <strong>pilocarpine</strong> is <strong>not</strong> specifically <strong>contraindicated in patients with diabetic macular edema.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Beta blocker:</strong> Beta blockers, such as <strong>timolol</strong>, work by <strong>decreasing the production of aqueous humor.</strong> They are a common choice for the <strong>treatment of glaucoma</strong> and do not directly affect the<strong> retina or exacerbate macular edema</strong>. Therefore, <strong>beta blockers </strong>can be considered for use in patients with<strong> both glaucoma and diabetic macular edema</strong>, provided there are <strong>no other contraindications (e.g., respiratory conditions).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with <strong>macular edema, prostaglandin analogues</strong> may exacerbate <strong>macular edema</strong> and should be used <strong>cautiously or avoided</strong>. It is important to consider the <strong>systemic and ocular side effects of glaucoma medications</strong>, especially in patients with <strong>pre-existing </strong>conditions such as<strong> diabetic retinopathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/2000_vzyqPnB.jpg\" style=\"height:1116px; width:1000px\" /></p>",
    "correct_choice_id": 13171,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3304,
    "choices": [
      {
        "id": 13195,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
      },
      {
        "id": 13196,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
      },
      {
        "id": 13197,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noradrenaline</span></span></span></p>"
      },
      {
        "id": 13198,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous infusion of which of the following drugs may result in decrease in heart rate?</span></span></span></p>",
    "unique_key": "Q4810860",
    "question_audio": null,
    "question_video": null,
    "map_id": 35879,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Noradrenaline </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline (norepinephrine)</strong> is a <strong>sympathomimetic amine </strong>that predominantly acts on <strong>alpha-adrenergic receptors</strong>, causing <strong>vasoconstriction and increasing blood pressure</strong>. Although it also has <strong>beta-1 adrenergic activity </strong>that can<strong> increase heart rate</strong>, the <strong>dominant effect </strong>of <strong>noradrenaline-induced vasoconstriction </strong>leads to a <strong>reflex bradycardia</strong>. This reflex is mediated by the <strong>baroreceptor</strong> reflex; as <strong>blood pressure </strong>rises due to <strong>vasoconstriction, </strong>the <strong>baroreceptors</strong> in the <strong>carotid sinus and aortic arch sense</strong> this <strong>increase and stimulate the vagus nerve </strong>to <strong>slow the heart rate </strong>in an attempt to <strong>balance the cardiovascular effects </strong>and<strong> maintain homeostasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline:&nbsp;</strong>Adrenaline (epinephrine) acts on <strong>both alpha and beta-adrenergic receptors. </strong>Its action on <strong>beta-1 receptors </strong>in the heart typically <strong>increases heart rate and cardiac output. </strong>Thus, intravenous <strong>infusion of adrenaline</strong> is more likely to <strong>increase rather</strong> than <strong>decrease heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Isoprenaline:&nbsp;</strong>Isoprenaline (isoproterenol) is a <strong>synthetic sympathomimetic amine </strong>that acts predominantly on <strong>beta-adrenergic receptors</strong>, including<strong> beta-1 receptors in the heart</strong>, leading to an <strong>increase in heart rate and cardiac output</strong>. It <strong>does not </strong>cause a<strong> decrease in heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dobutamine:</strong> Dobutamine is a <strong>beta-1 adrenergic agonist </strong>with <strong>strong inotropic effects </strong>but relatively <strong>mild chronotropic </strong>effects compared to <strong>isoprenaline</strong>. It primarily <strong>increases the strength of heart muscle contraction </strong>and slightly <strong>increases heart rate </strong>but is primarily used for <strong>its inotropic effect in heart failure</strong>. It is <strong>less likely </strong>to cause a<strong> decrease in heart rate </strong>compared to <strong>noradrenaline&#39;s reflex bradycardia effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>cardiovascular effects of different sympathomimetic amines</strong>, particularly their impact on<strong> heart rate</strong>. While <strong>adrenaline, isoprenaline, and dobutamine </strong>generally <strong>increase heart rate </strong>due to their<strong> beta-1 adrenergic receptor activity</strong>, <strong>noradrenaline </strong>can lead to a reflex <strong>decrease in heart rate (bradycardia) </strong>through <strong>increased blood pressure </strong>and <strong>subsequent activation of the baroreceptor reflex</strong>.</span></span></span></p>",
    "correct_choice_id": 13197,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3317,
    "choices": [
      {
        "id": 13247,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
      },
      {
        "id": 13248,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
      },
      {
        "id": 13249,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
      },
      {
        "id": 13250,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs can cross blood brain barrier? </span></span></span></p>",
    "unique_key": "Q1844164",
    "question_audio": null,
    "question_video": null,
    "map_id": 35882,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) i.e. Physostigmine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Physostigmine </strong>is known for its ability to be <strong>rapidly absorbed from the gastrointestinal tract </strong>and through <strong>parenteral administration</strong> <strong>routes.</strong> Its chemical structure allows it to <strong>penetrate the cornea and cross the blood-brain barrier (BBB)</strong>, thus exerting effects on the <strong>central nervous system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glycopyrrolate:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect,</strong> as it is a <strong>potent antimuscarinic agent</strong> with <strong>rapid action </strong>but <strong>lacks central effects </strong>due to its <strong>inability to cross the BBB. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Neostigmine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect</strong> because it is a<strong> quaternary ammonium compound</strong>, which results in <strong>poor oral absorption</strong>, <strong>limited</strong> <strong>corneal penetration</strong>, and an<strong> inability to cross the BBB.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to remember that <strong>physostigmine can cross the blood-brain barrier, </strong>distinguishing it from other <strong>anticholinesterases</strong> like<strong> neostigmine</strong> and <strong>antimuscarinics like glycopyrrolate, which cannot.</strong></span></span></span></p>",
    "correct_choice_id": 13249,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3318,
    "choices": [
      {
        "id": 13251,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle tremors</span></span></span></p>"
      },
      {
        "id": 13252,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
      },
      {
        "id": 13253,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemic attacks</span></span></span></p>"
      },
      {
        "id": 13254,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sedation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common adverse effect of short acting beta 2 agonists used in bronchial asthma is?</span></span></span></p>",
    "unique_key": "Q5453820",
    "question_audio": null,
    "question_video": null,
    "map_id": 35883,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Muscle tremors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle tremors </strong>are the most common adverse effect associated with <strong>beta-2 agonists</strong> due to the <strong>stimulation of beta-2 receptors</strong> in <strong>skeletal muscles</strong>. This effect is <strong>more pronounced </strong>when these medications are used at <strong>higher doses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypokalemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Incorrect, </strong>while <strong>beta-2 agonists </strong>can cause <strong>hypokalemia</strong> due to the <strong>intracellular shift of potassium, </strong>it is <strong>not</strong> the most common <strong>adverse effect. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypoglycemic attacks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Incorrect, hypoglycemia</strong> is <strong>not</strong> a typical adverse effect of <strong>beta-2 agonists. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sedation:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Incorrect,</strong> <strong>beta-2 agonists</strong> typically <strong>do no</strong>t cause <strong>sedation as an adverse effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common adverse effect of <strong>short-acting beta-2 agonists </strong>in the treatment of <strong>bronchial asthma is muscle tremors, </strong>which occur due to <strong>direct stimulation of the beta-2 receptors </strong>in<strong> skeletal muscles.</strong></span></span></p>",
    "correct_choice_id": 13251,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3321,
    "choices": [
      {
        "id": 13263,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fenoldopam </span></span></span></p>"
      },
      {
        "id": 13264,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
      },
      {
        "id": 13265,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine </span></span></span></p>"
      },
      {
        "id": 13266,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug possess agonistic property on alpha 1, alpha 2, beta 1 and beta 2 adrenergic receptors?</span></span></p>",
    "unique_key": "Q5085692",
    "question_audio": null,
    "question_video": null,
    "map_id": 35884,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Epinephrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine, </strong>also known as <strong>adrenaline,</strong> is a <strong>non-selective adrenergic agonist</strong> that stimulates <strong>both alpha- and beta-adrenergic</strong> <strong>receptors</strong>. It possesses <strong>agonistic properties on alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-1 adrenergic receptor</strong> activation causes<strong> vasoconstriction</strong>, leading to <strong>increased blood pressure.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-2 adrenergic receptor</strong> activation results in <strong>peripheral vasodilation</strong> and <strong>reduced peripheral resistance.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-1 adrenergic receptor </strong>activation<strong> increases heart rate, cardiac contractility, and conduction velocity </strong>in the heart.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 adrenergic receptor</strong> activation leads to<strong> bronchodilation and vasodilation </strong>in <strong>skeletal muscle </strong>and other <strong>vascular beds.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine </strong>is commonly used in<strong> emergency medicine </strong>for <strong>its effects </strong>on the<strong> cardiovascular system, bronchodilation</strong>, and <strong>its ability to counteract severe allergic reactions (anaphylaxis).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fenoldopam:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fenoldopam is a <strong>selective dopamine-1 receptor agonist </strong>used for the management of<strong> hypertension</strong>. It does <strong>not </strong>possess <strong>agonistic properties on alpha or beta adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dopamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dopamine primarily<strong> acts on dopamine receptors,</strong> but at<strong> higher doses,</strong> it can also stimulate <strong>alpha and beta</strong> <strong>adrenergic receptors</strong>. However, dopamine is <strong>not as potent</strong> or <strong>selective as epinephrine </strong>in its actions on <strong>adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Phenylephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Phenylephrine is a <strong>selective alpha-1 adrenergic receptor agonist</strong> used primarily as a <strong>decongestant</strong> and to <strong>raise blood pressure </strong>in cases of<strong> hypotension</strong>. It <strong>does not</strong> possess <strong>agonistic properties</strong> on<strong> beta adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine,</strong> as a<strong> non-selective adrenergic agonist</strong>, stimulates <strong>alpha-1, alpha-2, beta-1, and beta-2</strong> adrenergic receptors, leading to a wide range of<strong> cardiovascular and bronchodilatory effects.</strong> This knowledge guides its use in<strong> emergency situation</strong>s such as <strong>anaphylaxis, cardiac arrest, and severe asthma exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122030.jpg\" style=\"height:522px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13265,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3326,
    "choices": [
      {
        "id": 13283,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
      },
      {
        "id": 13284,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glaucoma</span></span></span></p>"
      },
      {
        "id": 13285,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></span></p>"
      },
      {
        "id": 13286,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-surgical atony or ileus</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinomimetic drugs are not used in which of the following conditions?</span></span></span></p>",
    "unique_key": "Q2784313",
    "question_audio": null,
    "question_video": null,
    "map_id": 35885,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bradycardia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs,</strong> which <strong>mimic the action of acetylcholine</strong>, are <strong>not</strong> used in the management of <strong>bradycardia. </strong>In fact, they could <strong>exacerbate bradycardia </strong>by <strong>stimulating muscarinic receptors in the heart, </strong>which can <strong>decrease heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong> because <strong>cholinomimetics like Pilocarpine</strong> are used to <strong>increase trabecular outflow</strong> and <strong>decrease</strong> <strong>intraocular pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Myasthenia gravis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as <strong>cholinomimetics</strong> improve <strong>muscle strength </strong>by <strong>enhancing neuromuscular transmission. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Post-surgical atony or ileus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>since <strong>cholinomimetics </strong>are used to <strong>stimulate GI motility </strong>and <strong>resolve atony or ileus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs</strong> should <strong>not </strong>be used to <strong>treat bradycardia</strong> as they can<strong> slow down the heart rate furthe</strong>r, being <strong>agonists at</strong> <strong>muscarinic receptors</strong> in the heart.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122644.jpg\" style=\"height:424px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 13283,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3334,
    "choices": [
      {
        "id": 13315,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></p>"
      },
      {
        "id": 13316,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
      },
      {
        "id": 13317,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acebutolol</span></span></span></p>"
      },
      {
        "id": 13318,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta adrenergic blocker having cardioselectivity, intrinsic sympathomimetic activity and membrane stabilizing property is? </span></span></span></p>",
    "unique_key": "Q8118589",
    "question_audio": null,
    "question_video": null,
    "map_id": 35868,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acebutolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acebutolol </strong>is the<strong> beta-blocker </strong>that possesses <strong>cardioselectivity, intrinsic sympathomimetic activity (ISA),</strong> and <strong>membrane-stabilizing</strong> <strong>activity (MSA).</strong> This makes it uniquely suited for patients who may <strong>benefit from </strong>these <strong>specific pharmacological properties</strong>. <strong>Acebutolol&#39;s cardioselectivity </strong>allows it to preferentially target <strong>beta-1 adrenergic receptors in the heart,</strong> which is desirable in patients with <strong>respiratory conditions like asthma, </strong>as it <strong>minimizes </strong>the risk of <strong>bronchoconstriction</strong> associated with<strong> beta-2 receptor blockade</strong>. Its <strong>intrinsic sympathomimetic activity </strong>offers mild <strong>agonistic effect</strong> at the <strong>same receptors it blocks,</strong> which can be<strong> beneficial in patients</strong> who need a<strong> beta-blocker</strong> but are at <strong>risk of bradycardia or have decreased cardiac output.</strong> The <strong>membrane-stabilizing activity,</strong> although <strong>not</strong> a primary therapeutic action when given at <strong>therapeutic doses</strong>, can contribute to its <strong>antiarrhythmic effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carvedilol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> non-selective beta-blocker </strong>with <strong>alpha-1 adrenergic blocking activity,</strong> making it effective in <strong>reducing blood pressure</strong> through <strong>vasodilation</strong>. It <strong>lacks intrinsic sympathomimetic activity</strong> and <strong>does not </strong>preferentially target <strong>beta-1 receptors</strong>, making it <strong>less ideal for patients</strong> with <strong>respiratory risks. Carvedilol </strong>is often chosen for <strong>its potent</strong> <strong>antihypertensive effects</strong> and <strong>benefits in heart failure</strong> management but <strong>does no</strong>t have the <strong>combined properties</strong> mentioned in the question.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Atenolol is a <strong>cardioselective beta-blocker,</strong> targeting <strong>beta-1 adrenergic receptors</strong>, which <strong>reduces its</strong> risk of <strong>bronchoconstriction </strong>in patients with<strong> asthma or chronic obstructive pulmonary disease (COPD).</strong> However, it <strong>lacks</strong> <strong>intrinsic sympathomimetic activity </strong>and<strong> does not</strong> have significant<strong> membrane-stabilizing activity,</strong> limiting its use in certain <strong>clinical scenarios </strong>where these properties are <strong>desired.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Metoprolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Similar to atenolol,</strong> metoprolol is cardioselective but <strong>does not</strong> possess <strong>intrinsic sympathomimetic</strong> <strong>activity</strong> or significant <strong>membrane-stabilizing activity.</strong> It is widely used for its<strong> cardiovascular benefits,</strong> including <strong>hypertension management, heart failure treatment</strong>, and <strong>myocardial infarction</strong> recovery, but it <strong>does not</strong> meet the criteria of having <strong>all three specified properties.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>pharmacological properties </strong>and <strong>clinical implications</strong> of <strong>selecting specific beta-blockers </strong>for <strong>treatment.</strong> Recognizing the u<strong>nique attributes of beta-blockers</strong>, such as <strong>cardioselectivity, intrinsic sympathomimetic activity,</strong> and <strong>membrane-stabilizing activity,</strong> is crucial in <strong>tailoring therapy</strong> to<strong> individual patient needs,</strong> especially considering <strong>potential comorbid</strong> <strong>conditions. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardioselective beta blockers: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/10.jpg\" style=\"height:1023px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers with intrinsic sympathomimetic activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/12.jpg\" style=\"height:548px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers with membrane stabilizing property&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/20.jpg\" style=\"height:526px; width:1000px\" /></p>",
    "correct_choice_id": 13317,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 3339,
    "choices": [
      {
        "id": 13335,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If A,B,C are correct</span></span></span></p>"
      },
      {
        "id": 13336,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If A and C are correct</span></span></span></p>"
      },
      {
        "id": 13337,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If B and D are correct</span></span></span></p>"
      },
      {
        "id": 13338,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If all 4 are correct</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are uses of cholinergic drugs owing to their muscarinic actions? </span></span></span></p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sjogren&rsquo;s syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&#39;s disease</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cobra bite</span></span></span></li>\r\n</ol>",
    "unique_key": "Q5673071",
    "question_audio": null,
    "question_video": null,
    "map_id": 35869,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) If A,B,C are correct</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drugs,</strong> which<strong> mimic</strong> the <strong>action of acetylcholine,</strong> have various<strong> therapeutic uses </strong>due to their <strong>muscarinic actions</strong>. Let&#39;s examine the options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A) Sjogren&rsquo;s syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drugs </strong>are used to <strong>stimulate saliva and tear production in patients </strong>with <strong>Sjogren&rsquo;s syndrome, </strong>a condition characterized by <strong>dry mouth and dry eyes </strong>due to <strong>autoimmune destruction </strong>of the <strong>salivary and lacrimal glands. </strong>Their <strong>muscarinic actions</strong> enhance<strong> glandular secretion.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B) Alzheimer&#39;s disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Cholinergic drugs, specifically <strong>cholinesterase inhibitors,</strong> are used in <strong>Alzheimer&#39;s disease</strong> to <strong>increase acetylcholine levels</strong> in the <strong>brain </strong>and<strong> improve cognitive function. </strong>This <strong>acetylcholine</strong> works on<strong> muscarinic</strong> <strong>receptors</strong> to <strong>improve memory. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C) Paralytic ileus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drug</strong>s are used to <strong>stimulate gastrointestinal motility</strong> in conditions like<strong> paralytic</strong> <strong>ileus</strong> by acting on <strong>muscarinic receptors in the gut, </strong>thereby <strong>alleviating the condition.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D) Cobra bite:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Treatment for a cobra bite</strong> primarily involves<strong> antivenom and supportive care. Cholinergic drugs</strong> like<strong> neostigmine</strong> is used to <strong>stimulate the Nm receptors </strong>and <strong>reverse </strong>the actions of the <strong>venom on neuromuscular</strong> <strong>junction. </strong>However the <strong>therapeutic</strong> approach <strong>does not </strong>center on <strong>muscarinic actions of cholinergic drugs </strong>in this condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Sjogren&rsquo;s syndrome),</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Option B (Alzheimer&#39;s disease) and Option C (Paralytic ileus)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are correct uses of <strong>cholinergic drugs</strong> due to their<strong> muscarinic actions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Cobra bite)</span></strong><strong> </strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is use of<strong> cholinergic drugs</strong> due to action on <strong>nicotinic receptors </strong>and not muscarinic action.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>therapeutic applications of cholinergic drugs,</strong> particularly through their<strong> muscarinic</strong> <strong>actions</strong>, in various medical conditions. Recognizing how these drugs work can <strong>help in selecting appropriate treatment </strong>options for conditions like <strong>Sjogren&rsquo;s syndrome, Alzheimer&rsquo;s disease and paralytic ileus,</strong> while also understanding the <strong>limitations and specificity</strong> of their<strong> use </strong>in<strong> other disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/121.jpg\" style=\"height:608px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/222.jpg\" style=\"height:680px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13335,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3347,
    "choices": [
      {
        "id": 13367,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
      },
      {
        "id": 13368,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></p>"
      },
      {
        "id": 13369,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxprenolol</span></span></p>"
      },
      {
        "id": 13370,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following beta blockers can cross blood brain barrier except? </span></span></span></p>",
    "unique_key": "Q4978319",
    "question_audio": null,
    "question_video": null,
    "map_id": 35871,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Atenolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipid soluble beta blockers </strong>can <strong>cross blood brain barrier</strong> whereas<strong> water soluble beta blockers cannot.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Water soluble beta blockers</strong> include:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A: A</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">tenolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">N: N</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">adolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">S: S</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">otalol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The <strong>ability </strong>of a <strong>beta-blocker </strong>to <strong>cross the blood-brain barrier</strong> is influenced by <strong>its solubility. Lipid-soluble drugs</strong> can <strong>cross more easily,</strong> while <strong>water-soluble drugs do not</strong>. This <strong>property affects the drug&#39;s central nervous system side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol:</strong> A <strong>lipid-soluble beta-blocker</strong> that <strong>can cross the blood-brain barrier</strong> and may cause<strong> CNS side effects. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxprenolol:</strong> A <strong>lipid-soluble beta-blocker </strong>with <strong>partial lipid solubility </strong>and can have<strong> some penetration into the CNS. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Timolol:</strong> A<strong> beta-blocker </strong>with some <strong>lipid solubility, </strong>which allows it to <strong>cross the blood-brain barrier.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atenolol is a water-soluble beta-blocker </strong>that <strong>does not cross the blood-brain barrie</strong>r, making it a preferable option for patients at <strong>risk</strong> of <strong>CNS side effects </strong>and requiring careful use in<strong> patients with renal impairment</strong> due to its <strong>excretion predominantly </strong>via the <strong>kidneys.</strong></span></span></span></p>",
    "correct_choice_id": 13368,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3289,
    "choices": [
      {
        "id": 13135,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
      },
      {
        "id": 13136,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13137,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
      },
      {
        "id": 13138,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following drugs increases gastrointestinal motility?</span></span></span></p>",
    "unique_key": "Q5455340",
    "question_audio": null,
    "question_video": null,
    "map_id": 35942,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Neostigmine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine increases gastrointestinal motility </strong>by inhibiting <strong>acetylcholinesterase</strong>, the enzyme responsible for <strong>breaking down</strong> <strong>acetylcholine at cholinergic synapses</strong>. This action results in an <strong>increased concentration of acetylcholine</strong> at the neuromuscular junctions within the <strong>gastrointestinal tract,</strong> enhancing<strong> smooth muscle contraction </strong>and thereby <strong>promoting gastrointestinal motility.</strong> <strong>Neostigmine&#39;s </strong>effect on the <strong>gastrointestinal system</strong> is part of its broader pharmacological profile as a<strong> parasympathomimetic agent,</strong> which<strong> stimulates the parasympathetic nervous system</strong> and can be used to treat conditions such as <strong>postoperative abdomina</strong>l <strong>distension and urinary retention.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate:</strong> Glycopyrrolate is an <strong>anticholinergic drug </strong>that <strong>decreases gastrointestinal motility.</strong> It works by blocking <strong>acetylcholine receptors </strong>in the<strong> gastrointestinal tract</strong>, <strong>reducing smooth muscle contractions and secretions</strong>. <strong>Glycopyrrolate </strong>is often used<strong> preoperatively to reduce salivary, tracheobronchial, and pharyngeal secretions</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is another <strong>anticholinergic drug </strong>that <strong>reduces gastrointestinal motility </strong>by inhibiting the action of <strong>acetylcholine on muscarinic receptors in the gut</strong>. This results in <strong>decreased muscle tone and motility</strong> in the <strong>digestive tract.</strong> Atropine is used in various clinical settings, including <strong>pre-anesthetic medication</strong> to <strong>reduce salivation and increase heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fentanyl:</strong> Fentanyl is a<strong> synthetic opioid analgesic, </strong>which<strong> does not </strong>directly affect<strong> gastrointestinal motility </strong>as<strong> its primary action</strong>. However, <strong>opioids</strong>, in general, are known to <strong>reduce gastrointestinal motility </strong>due to their <strong>inhibitory effects </strong>on the <strong>enteric nervous system</strong>, leading to <strong>constipation </strong>as a common side effect.<strong> Fentanyl&#39;s main </strong>use is for <strong>pain management</strong>, <strong>not for modulating gastrointestinal motility</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine</strong>, a <strong>parasympathomimetic agent</strong>, <strong>increases gastrointestinal motility</strong> by <strong>inhibiting acetylcholinesterase</strong> and <strong>increasing</strong> <strong>acetylcholine levels</strong>. In contrast, <strong>anticholinergic drugs like glycopyrrolate and atropine decrease gastrointestinal motility </strong>by blocking <strong>acetylcholine receptors.</strong> <strong>Fentanyl, an opioid analgesic, </strong>can<strong> indirectly decrease gastrointestinal motility </strong>as a side effect of its<strong> analgesic use. </strong></span></span></p>",
    "correct_choice_id": 13137,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3312,
    "choices": [
      {
        "id": 13227,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organophosphate poisoning</span></span></span></p>"
      },
      {
        "id": 13228,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></span></span></p>"
      },
      {
        "id": 13229,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning</span></span></span></p>"
      },
      {
        "id": 13230,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pontine hemorrhage</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents to emergency with pinpoint pupil, salivation, lacrimation, tremors and red tears. Plasma cholinesterase level was 30% of normal. Most probable Diagnosis is? </span></span></span></p>",
    "unique_key": "Q2304902",
    "question_audio": null,
    "question_video": null,
    "map_id": 35937,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Organophosphate poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of <strong>pinpoint pupils (miosis), excessive salivation, lacrimation, muscle tremors, </strong>and the unusual finding of <strong>red tears</strong>, combined with significantly <strong>reduced plasma cholinesterase levels (30% of normal), </strong>strongly suggests <strong>organophosphate poisoning. </strong>Organophosphates <strong>inhibit acetylcholinesterase, </strong>leading to the <strong>accumulation of acetylcholine at cholinergic synapses and neuromuscular junctions</strong>. This results in <strong>overstimulation of muscarinic and nicotinic receptors</strong>, manifesting as the <strong>muscarinic signs (miosis, salivation, lacrimation) and nicotinic signs (muscle tremors) </strong>observed.<strong> Organophosphates </strong>are commonly used in agriculture as <strong>pesticides</strong>, and <strong>exposure </strong>can occur through <strong>inhalation, ingestion, or skin contact</strong>, which is consistent with the patient being a<strong> farm worker</strong>. The <strong>red tears </strong>could be related to <strong>conjunctival </strong>exposure to the <strong>chemical or a secondary effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dhatura poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dhatura</strong>, a <strong>plant </strong>containing <strong>anticholinergic tropane alkaloids </strong>(e.g., <strong>atropine, scopolamine</strong>), would cause <strong>anticholinergic syndrome</strong>, characterized by <strong>dry skin and mucous membranes, flushed face, hyperthermia, mydriasis (dilated pupils), and hallucinations. </strong>This is<strong> opposite to the cholinergic signs </strong>seen in the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Opioid poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning can cause <strong>pinpoint pupils</strong>, but the predominant symptoms would also include <strong>respiratory depression and decreased level of consciousness</strong>, which are not mentioned in the scenario. <strong>Opioids do not </strong>cause <strong>excessive salivation or lacrimation</strong>, nor do they affect <strong>plasma cholinesterase levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pontine hemorrhage:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While pontine hemorrhage can lead to<strong> pinpoint pupils </strong>due to disruption of the <strong>sympathetic pathways</strong>, it would also typically present with <strong>acute neurological deficits like altered consciousness, paralysis, or other focal neurological signs</strong>, which are not described in this scenario. Additionally,<strong> pontine hemorrhage </strong>would <strong>not explain </strong>the <strong>reduced plasma cholinesterase levels </strong>or the specific combination of symptoms mentioned.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to recognize the <strong>clinical presentation of organophosphate poisoning,</strong> which includes signs of <strong>cholinergic</strong> excess such as <strong>miosis, excessive salivation, lacrimation, and muscle tremors,</strong> along with <strong>reduced plasma cholinesterase levels</strong>. <strong>Understanding the clinical features and laboratory findings </strong>associated with this condition is critical for<strong> prompt diagnosis and treatment</strong>.</span></span></span></p>",
    "correct_choice_id": 13227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3351,
    "choices": [
      {
        "id": 13383,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></p>"
      },
      {
        "id": 13384,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
      },
      {
        "id": 13385,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></p>"
      },
      {
        "id": 13386,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-glaucoma drug that acts by increasing uveoscleral outflow is:</span></span></span></p>",
    "unique_key": "Q1003133",
    "question_audio": null,
    "question_video": null,
    "map_id": 35940,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Latanoprost</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Latanoprost</strong> is an <strong>anti-glaucoma medication</strong> that works by <strong>increasing the uveoscleral outflow of aqueous humor, </strong>which helps to <strong>lower intraocular pressure </strong>in patients with<strong> glaucoma or ocular hypertension.</strong> It is a <strong>prostaglandin analog,</strong> which <strong>distinguishes its</strong> <strong>mechanism of action</strong> from other classes of <strong>glaucoma medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Timolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Timolol is a<strong> beta-blocke</strong>r used in the <strong>treatment of glaucoma,</strong> but it works by <strong>decreasing aqueous</strong> <strong>humor production in the eye,</strong> not by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dorzolamide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Dorzolamide is a carbonic anhydrase inhibitor</strong> that also<strong> reduces intraocular pressure</strong> by <strong>decreasing aqueous humor production</strong>. It does not act by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pilocarpine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pilocarpine is a muscarinic agonist</strong> that reduces i<strong>ntraocular pressure by increasing the outflow of</strong> <strong>aqueous humor</strong> through the <strong>trabecular meshwork,</strong> which is different from increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to recognize the<strong> mechanism of action </strong>of different <strong>anti-glaucoma medications</strong>, particularly identifying <strong>latanoprost as</strong> a drug that<strong> reduces intraocular pressure </strong>by <strong>increasing uveoscleral outflow. </strong>Understanding how various <strong>anti-glaucoma </strong>drugs work is essential for selecting appropriate treatment options based on the individual needs and pathophysiology of the patient&#39;s glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of anti-glaucoma drugs</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/99.jpg\" style=\"height:359px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 13383,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3325,
    "choices": [
      {
        "id": 13279,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirenzepine </span></span></span></p>"
      },
      {
        "id": 13280,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolterodine</span></span></span></p>"
      },
      {
        "id": 13281,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide </span></span></span></p>"
      },
      {
        "id": 13282,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an antimuscarinic drug useful in overactive bladder?</span></span></span></p>",
    "unique_key": "Q3853219",
    "question_audio": null,
    "question_video": null,
    "map_id": 35944,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp; B) Tolterodine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Overactive bladder (Detrusor instability)</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Detrusor instability or overactive bladder </strong>is characterized by <strong>uninhibited, unstable contractions of the detrusor muscle.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since <strong>detrusor contracts</strong> under <strong>parasympathetic influence</strong>, <strong>anticholinergic drugs</strong> are used to <strong>treat overactive bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents<strong> lower intravesical pressure</strong>,<strong> increase capacity </strong>and<strong> reduce the frequency of contractions</strong> by <strong>antagonizing</strong> <strong>parasympathetic tone of bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents include: -</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olefenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; O</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">xybutynin </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lavoxate</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olterodine and <strong>T</strong>rospium</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bla<strong>DAR:</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>DAR</strong>ifenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A. Pirenzepine:</strong> Pirenzepine is primarily used as a<strong> selective M1 muscarinic receptor antagonist</strong> in the treatment of <strong>peptic</strong> <strong>ulcers.</strong> It is <strong>not indicated </strong>for the treatment of<strong> overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tropicamide:</strong> Tropicamide is a<strong> muscarinic receptor antagonist </strong>used as a <strong>mydriatic agent</strong> to induce <strong>pupillary dilation</strong> for <strong>ophthalmic examinations. </strong>It is <strong>not indicated</strong> for the treatment of <strong>overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is a <strong>non-selective muscarinic receptor antagonist</strong> used for various purposes, including the <strong>treatment of bradycardia, organophosphate poisoning, </strong>and as a<strong> preanesthetic medication</strong>. While it can <strong>reduce detrusor muscle activity</strong>, it is <strong>not </strong>commonly used for the<strong> treatment of overactive bladder</strong> due to its<strong> non-selective nature and potential side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tolterodine,</strong> as an <strong>antimuscarinic agent, </strong>is commonly used in the <strong>treatment of overactive bladder</strong> due to its <strong>ability to reduce urinary frequency, urgency, and urge incontinence </strong>by <strong>blocking muscarinic receptors</strong> in the<strong> bladder. </strong></span></span></p>",
    "correct_choice_id": 13280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3309,
    "choices": [
      {
        "id": 13215,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;1</span></span></span></p>"
      },
      {
        "id": 13216,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;2</span></span></span></p>"
      },
      {
        "id": 13217,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and &beta;2</span></span></span></p>"
      },
      {
        "id": 13218,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and antagonist at &alpha;1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing of a drug related to autonomic nervous system was planned. The drug and a placebo were administered in a healthy volunteer? The following effect were seen. What are the likely characteristics of the drug?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121656.jpg\" style=\"height:516px; width:1000px\" /></span></span></span></p>",
    "unique_key": "Q3596102",
    "question_audio": null,
    "question_video": null,
    "map_id": 35935,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Agonist at &beta;1 and &beta;2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> drug shows </strong>characteristics of<strong> increased heart rate (tachycardia) and increased systolic blood pressure</strong>, which are indicative of <strong>&beta;1 agonist action.</strong> The <strong>decrease in diastolic blood pressure </strong>and the<strong> presence of tremors suggest &beta;2 agonist </strong>activity, as <strong>&beta;2 receptors</strong> are responsible for <strong>vasodilation in certain blood vessels </strong>and can cause<strong> tremors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Agonist at &alpha;1 and &beta;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect </strong>because <strong>&alpha;1 stimulation </strong>would <strong>increase both systolic and diastolic blood pressure,</strong> which is not observed. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Agonist at &alpha;1 and &beta;2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrec</strong>t because <strong>&alpha;1 agonist action</strong> would<strong> not</strong> result in<strong> decreased diastolic blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Agonist at &beta;1 and antagonist at &alpha;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Incorrect</strong> because an <strong>&alpha;1 antagonist</strong> would lead to a<strong> decrease in both systolic and diastolic blood pressure, not an increase in systolic pressure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic effects of<strong> tachycardia and changes in blood pressure,</strong> along with the <strong>presence of tremors</strong>, suggest that the drug has <strong>agonistic activity at &beta;1 and &beta;2 receptors,</strong> making it a likely candidate for a <strong>beta-adrenergic agonist</strong> with <strong>both cardiac and</strong> <strong>peripheral actions.</strong></span></span></p>",
    "correct_choice_id": 13217,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3275,
    "choices": [
      {
        "id": 13079,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5&ndash;1 kg </span></span></span></p>"
      },
      {
        "id": 13080,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.5&ndash;2.5 kg </span></span></span></p>"
      },
      {
        "id": 13081,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5&ndash;7 kg</span></span></span></p>"
      },
      {
        "id": 13082,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10&ndash;12 kg</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the usual weight of rabbit used in ophthalmological experiments? </span></span></span></p>",
    "unique_key": "Q8789306",
    "question_audio": null,
    "question_video": null,
    "map_id": 35934,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1.5&ndash;2.5 kg</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laboratory animals </strong>used for various experiments include<strong> rat, mice, guinea pig, rabbit and hamster.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Weight of rats</strong> used in these experiments is <em>180-200 g </em>whereas that of <strong>rabbit is 1.5-2.5 Kg.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scientific name of <strong>rabbit is Oryctalagus cuniculus.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The typical <strong>weight for rabbits</strong> used in<strong> ophthalmological experiments</strong> is <strong>1.5 to 2.5 kilograms. </strong></span></span></span></p>",
    "correct_choice_id": 13080,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3283,
    "choices": [
      {
        "id": 13111,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a selective alpha 2 receptor agonist</span></span></span></p>"
      },
      {
        "id": 13112,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It decreases central sympathetic outflow</span></span></span></p>"
      },
      {
        "id": 13113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It increases the release of renin</span></span></span></p>"
      },
      {
        "id": 13114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be used for treatment of hypertension. </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is not true about clonidine?</span></span></span></p>",
    "unique_key": "Q4419113",
    "question_audio": null,
    "question_video": null,
    "map_id": 35939,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It increases the release of renin&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clonidine </strong>is a <strong>selective &alpha;2 adrenergic receptor </strong>agonist that d<strong>ecreases sympathetic outflow from the central nervous system</strong>, leading to <strong>decreased blood pressure and heart rate.</strong> It<strong> reduces the release of renin</strong> from the kidneys due to its <strong>inhibitory effect</strong> on <strong>sympathetic activity.</strong> Clonidine<strong> does not increase renin release</strong>; rather, it <strong>decreases</strong> it by lessensing the <strong>stimulation of &beta;1 receptors</strong> in the<strong> juxtaglomerular cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Acts as a <strong>selective &alpha;2 receptor agonist.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Stimulation of alpha 2A receptors</strong> in <strong>brainstem</strong> result in <strong>decrease sympathetic outflow</strong>&mdash;, <strong>fall in BP and bradycardia </strong>(also due to enhanced vagal tone).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used to treat various conditions including<strong> hypertension, menopausal syndrome, and withdrawal syndromes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline </strong>is specific to<strong> &alpha;1, &alpha;2, and &beta;1 receptors </strong>and <strong>does not activate &beta;2 receptors</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clonidine, an &alpha;2 receptor agonist</strong>, <strong>decreases sympathetic outflow </strong>and <strong>renin release</strong>, contrary to increasing it, which is an important consideration in its pharmacological profile and clinical use.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 13113,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3288,
    "choices": [
      {
        "id": 13131,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases gastric secretion</span></span></span></p>"
      },
      {
        "id": 13132,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolongs A-V conduction</span></span></span></p>"
      },
      {
        "id": 13133,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases tracheobronchial secretions</span></span></span></p>"
      },
      {
        "id": 13134,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Results in unopposed contraction of radial muscle of iris</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are actions of a muscarinic antagonist except?</span></span></span></p>",
    "unique_key": "Q9592958",
    "question_audio": null,
    "question_video": null,
    "map_id": 35941,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Prolongs A-V conduction </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscarinic antagonists,</strong> such as <strong>atropine</strong>, primarily block the actions of <strong>acetylcholine at muscarinic receptors</strong>, which are part of the <strong>parasympathetic nervous system</strong>. Their effects include <strong>dilation of the pupils, decreased secretion in the airways and stomach</strong>, and <strong>increased heart rate</strong>. However, the specific action on heart conduction is often misunderstood:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolongs A-V conduction&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>incorrect </strong>in the context of <strong>muscarinic antagonists&#39; effects</strong>. These agents typically <strong>shorten A-V conduction </strong>time, <strong>not prolong </strong>it, by blocking the <strong>muscarinic receptors in the heart </strong>that mediate the <strong>vagal tone&#39;s</strong> slowing effect on <strong>heart rate and conduction.</strong> This results in an<strong> increased heart rate (tachycardia) </strong>and can <strong>facilitate faster</strong> <strong>A-V nodal conduction</strong>, opposite to prolongation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Decreases gastric secretion:</strong> <strong>Correct. Muscarinic antagonists reduce gastric acid secretion </strong>by blocking the<strong> muscarinic M3</strong> <strong>receptors</strong> on the gastric parietal cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Decreases tracheobronchial secretions:</strong> <strong>Correct.</strong> These agents<strong> reduce secretions</strong> in the <strong>airway</strong> by <strong>inhibiting muscarinic</strong> <strong>receptors</strong> in the bronchial glands.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Causes unopposed contraction of radial muscle of iris:</strong> <strong>Muscarinic antagonists </strong>cause <strong>pupil dilation (mydriasis)</strong> by blocking the<strong> M3 receptors</strong> on the<strong> sphincter pupillae muscle</strong>. However, the<strong> pupil</strong> is also supplied by the <strong>radial muscle, </strong>which is controlled by <strong>sympathetic innervation.</strong> Therefore, when <strong>M3 receptors are blocked by anticholinergic drugs</strong>, <strong>sphincter pupillae</strong> <strong>cannot contrac</strong>t and there is unopposed<strong> contraction of radial muscles </strong>via<strong> sympathetic system </strong>leading to <strong>dilation of pupil</strong>. This is known as <strong>passive mydriasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Muscarinic antagonists shorten A-V conduction </strong>time rather than prolonging it, which reflects their overall effect of<strong> reducing parasympathetic activity on the heart</strong>.</span></span></p>",
    "correct_choice_id": 13132,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3294,
    "choices": [
      {
        "id": 13155,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 hours</span></span></span></p>"
      },
      {
        "id": 13156,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12 hours</span></span></span></p>"
      },
      {
        "id": 13157,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 day</span></span></span></p>"
      },
      {
        "id": 13158,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-2 weeks</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cycloplegic action of atropine lasts upto? </span></span></span></p>",
    "unique_key": "Q5351403",
    "question_audio": null,
    "question_video": null,
    "map_id": 35945,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1-2 weeks </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>is a <strong>potent muscarinic antagonist </strong>with a broad range of pharmacological effects, including <strong>cycloplegia</strong>, which is <strong>paralysis </strong>of the <strong>ciliary muscle of the eye</strong>, resulting in a <strong>loss of accommodation, and mydriasis</strong>, which is <strong>dilation of the pupil</strong>. The <strong>cycloplegic action of atropine </strong>is particularly <strong>long-lasting</strong>. When <strong>administered in the eye</strong>, <strong>atropine </strong>can cause <strong>cycloplegia </strong>that lasts up to<strong> 1-2 weeks</strong>. This <strong>extended duration </strong>is <strong>due to its strong affinity </strong>for<strong> muscarinic receptors </strong>and its <strong>relatively slow rate of dissociation </strong>from these<strong> receptors</strong>, leading to prolonged effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The <strong>educational objective </strong>is to recognize the <strong>duration of the cycloplegic effect </strong>of different drugs used in <strong>ophthalmic applications</strong>. Understanding the<strong> long-lasting action of atropine </strong>is crucial for <strong>healthcare </strong>providers in managing conditions requiring<strong> cycloplegia, such as uveitis</strong>, where <strong>prolonged pupil dilation and paralysis of accommodation are beneficial</strong>. </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120249.jpg\" style=\"height:263px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 13158,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3300,
    "choices": [
      {
        "id": 13179,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-1 agonist action leading to peripheral vasoconstriction</span></span></span></p>"
      },
      {
        "id": 13180,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in renal perfusion due to agonist action on D1 receptors</span></span></span></p>"
      },
      {
        "id": 13181,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Releases noradrenaline and causes positive inotropic effect</span></span></span></p>"
      },
      {
        "id": 13182,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct action on heart via beta-1 receptors</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient with a history of hypertension and diabetes is brought to the emergency department in a state of acute shock. He is hypotensive with a blood pressure of 80/50 mmHg, tachycardic with a heart rate of 110 bpm, and his skin is cold and clammy. The medical team is considering the use of dopamine as part of his management. Among the following properties of dopamine. Which of them is not helpful in acute shock?</span></span></span></p>",
    "unique_key": "Q8490319",
    "question_audio": null,
    "question_video": null,
    "map_id": 35932,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Increase in renal perfusion due to agonist action on D1 receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in renal perfusion due to agonist action on D1 receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Dopamine&#39;s action</strong> on <strong>D1 receptors</strong> in the<strong> renal vasculature</strong> can <strong>increase renal blood flow.</strong> This is potentially beneficial in maintaining <strong>renal function</strong> and<strong> preventing acute kidney injury</strong>, a common <strong>complication of shock</strong>. However, in the context of <strong>acute shock management</strong>, where the primary goal is to<strong> stabilize hemodynamic,</strong> this <strong>renal perfusion effect </strong>is <strong>not</strong> the primary therapeutic aim but can be considered a beneficial effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Alpha-1 agonist action leading to peripheral vasoconstriction:</strong>&nbsp;<strong>In shock,</strong> especially <strong>distributive shock (e.g., septic shock),</strong> <strong>peripheral vasodilation</strong> is a common issue <strong>leading to hypotension. T</strong>he <strong>alpha-1 agonist</strong> action of <strong>dopamine</strong> causes <strong>peripheral</strong> <strong>vasoconstriction</strong>, which can help <strong>increase systemic vascular resistance</strong> and thereby <strong>raise blood pressure</strong>. This action is beneficial in <strong>acute shock management.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Releases noradrenaline and causes positive inotropic effect:</strong>&nbsp;Dopamine causes the release of <strong>noradrenaline</strong> <strong>(norepinephrine) </strong>and exerts a<strong> positive inotropic effect </strong>(<strong>increasing cardiac contractility</strong>). The release of noradrenaline can occur by three mechanisms:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">Dopamine is a key intermediate in the biosynthesis of norepinephrine. Therefore, increased availability of dopamine leads to increased synthesis of norepinephrine.</span></li>\r\n\t<li><span style=\"font-size:16px\">Beta 1 receptors are present presynpatically in sympathetic nerve terminals. Stimulation of these receptors by dopamine&nbsp;can cause the release of stored norepinephrine.</span></li>\r\n\t<li><span style=\"font-size:16px\">Dopamine can also cause&nbsp;<strong>indirect release of norepinephrine</strong>&nbsp;by increasing intracellular calcium in sympathetic nerve terminals. This increase in calcium facilitates the exocytosis of norepinephrine-containing vesicles, leading to the release of norepinephrine into the synaptic cleft.</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This action is <strong>highly beneficial in shock</strong>, particularly in<strong> cardiogenic shock, </strong>where the <strong>heart&#39;s ability</strong> to <strong>pump blood is compromised. </strong>The <strong>positive inotropic effect </strong>helps improve<strong> cardiac output.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Direct action on heart via beta-1 receptors:&nbsp;Dopamine&#39;s</strong> direct action on <strong>beta-1 receptors</strong> in the heart <strong>increases heart</strong> <strong>rate and contractility.</strong> In <strong>acute shock</strong>, especially in cases where <strong>cardiac output is low,</strong> this action can be beneficial in <strong>improving</strong> <strong>hemodynamics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on this analysis, the option that is &quot;not helpful&quot; in the acute management of shock is option b - <strong>&quot;Increase in renal perfusion</strong> due to <strong>agonist action on D1 receptors</strong>&quot;. While it is beneficial for <strong>renal protection,</strong> it is <strong>not</strong> directly involved in the<strong> immediate</strong> <strong>hemodynamic stabiliatzion</strong> which is the primary goal.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of<strong> acute shock, </strong>the priority is to <strong>stabilize hemodynamics</strong>, which includes<strong> improving cardiac output</strong> and <strong>increasing systemic vascular resistance.</strong> <strong>Dopamine&#39;s alpha-1 agonist </strong>action, which causes <strong>peripheral vasoconstriction,</strong> and its<strong> beta-1 </strong>effects, which <strong>increase cardiac contractility and heart rate</strong>, are the key beneficial properties in this context. The effect of <strong>dopamine</strong> <strong>on D1 receptors</strong> to <strong>increase renal perfusion</strong>, while potentially <strong>protective for kidney function,</strong> is<strong> not</strong> the primary focus during the initial management of<strong> acute shock.</strong></span></span></p>",
    "correct_choice_id": 13180,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3310,
    "choices": [
      {
        "id": 13219,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopaminergic</span></span></span></p>"
      },
      {
        "id": 13220,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinergic</span></span></span></p>"
      },
      {
        "id": 13221,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic</span></span></span></p>"
      },
      {
        "id": 13222,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonergic</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are receptors are present on the ganglion?</span></span></span></p>",
    "unique_key": "Q4179005",
    "question_audio": null,
    "question_video": null,
    "map_id": 35936,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cholinergic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>autonomic ganglia</strong>, where <strong>preganglionic neurons synapse </strong>with <strong>postganglionic neurons,</strong> the <strong>primary neurotransmitter</strong> is <strong>acetylcholine.</strong> The receptors present on the <strong>neurons in the ganglion</strong> that respond to <strong>acetylcholine are nicotinic cholinergic receptors,</strong> which are a<strong> type of cholinergic receptor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>receptors respond to acetylcholin</strong>e. Specifically, <strong>nicotinic cholinergic receptors</strong> are found in <strong>autonomic ganglia</strong> and mediate<strong> fast synaptic transmission </strong>between<strong> preganglionic and postganglionic neurons</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dopaminergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These receptors respond to <strong>dopamine </strong>and are <strong>not </strong>typically <strong>found in autonomic ganglia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Adrenergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These<strong> receptors respond to norepinephrine and epinephrine </strong>and are generally <strong>not found on neurons in the ganglia</strong>. They are typically<strong> located on the target organs </strong>innervated by <strong>postganglionic sympathetic neurons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Serotonergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>receptors </strong>respond to <strong>serotonin </strong>and are <strong>not </strong>present in the <strong>autonomic ganglia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All <strong>preganglionic fibres (Both sympathetic as well as parasympathetic) </strong>secrete<strong> Ach </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-ganglionic parasympathetic fibres </strong>secrete<strong> Ach </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-ganglionic sympathetic fibres </strong>secrete mostly<strong> noradrenaline.</strong></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 13220,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3314,
    "choices": [
      {
        "id": 13235,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol</span></span></span></p>"
      },
      {
        "id": 13236,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sotalol</span></span></span></p>"
      },
      {
        "id": 13237,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol</span></span></span></p>"
      },
      {
        "id": 13238,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is beta</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> blocker with nitric oxide releasing property? &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>",
    "unique_key": "Q7545270",
    "question_audio": null,
    "question_video": null,
    "map_id": 35938,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Nebivolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol </strong>is a unique <strong>beta-blocker </strong>that possesses <strong>nitric oxide (NO) releasing properties</strong>. It acts as a <strong>selective beta-1 adrenergic</strong> <strong>receptor blocker </strong>and also <strong>promotes vasodilation </strong>by stimulating the <strong>release of nitric oxide</strong> from endothelial cells. This vasodilatory effect helps<strong> counteract the vasoconstrictive actions </strong>of traditional <strong>beta-blockers,</strong> contributing to its <strong>antihypertensive efficacy.</strong> <strong>Nebivolol </strong>is used in the <strong>management of hypertension and heart failure,</strong> and its<strong> NO-releasing property</strong> sets it <strong>apart from other beta-blockers </strong>in terms of its<strong> vasodilatory effects</strong> and potential advantages in certain patient populations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sotalol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Sotalol is a<strong> non-selective beta-blocker with Class III antiarrhythmic </strong>properties due to its <strong>inhibition of potassium</strong> <strong>channels in cardiac tissue</strong>. It does not have nitric oxide-releasing properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Betaxolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Betaxolol is a <strong>selective beta-1 adrenergic receptor blocker</strong> used primarily in the treatment of<strong> glaucoma and</strong> <strong>ocular hypertension.</strong> It <strong>does not </strong>possess <strong>nitric oxide-releasing properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Atenolol is a <strong>selective beta-1 adrenergic receptor blocker</strong> commonly used in the management of <strong>hypertension</strong> <strong>and angina.</strong> It <strong>does not </strong>have<strong> nitric oxide-releasing properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol</strong> stands out among <strong>beta-blockers</strong> due to its unique <strong>nitric oxide-releasing property, </strong>which contributes to its<strong> vasodilatory</strong> <strong>effects and potential advantages </strong>in the treatment of <strong>hypertension and heart failure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers releasing nitric oxide (NO)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebuvilol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nipradilol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bopindolol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carteolol</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 13235,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3323,
    "choices": [
      {
        "id": 13271,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 13272,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinsonism</span></span></span></p>"
      },
      {
        "id": 13273,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain Barre syndrome</span></span></span></p>"
      },
      {
        "id": 13274,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To produce mydriasis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an indication of an anticholinesterase drug?</span></span></span></p>",
    "unique_key": "Q8406215",
    "question_audio": null,
    "question_video": null,
    "map_id": 35943,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Alzheimer&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase drugs</strong> work by <strong>inhibiting the enzyme acetylcholinesterase,</strong> which<strong> breaks down acetylcholine,</strong> thus<strong> increasing its</strong> <strong>availability </strong>and action in the<strong> neural synapses</strong>. <strong>Alzheimer&rsquo;s disease</strong> is characterized by a <strong>deficiency of acetylcholine,</strong> and <strong>anticholinesterase drugs</strong> are used to <strong>mitigate this deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Parkinsonism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because the <strong>primary neurotransmitter</strong> affected in<strong> Parkinsonism is dopamine, </strong>not acetylcholine. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Guillain Barre syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as this is an <strong>autoimmune condition</strong> affecting <strong>peripheral nerves</strong>, and <strong>anticholinesterase drugs </strong>are not the mainstay of treatment. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. To produce mydriasis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because <strong>anticholinesterase drugs do not produce mydriasis</strong>; they are used to <strong>treat</strong> conditions like<strong> glaucoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase drugs </strong>are used in the treatment of <strong>Alzheimer&rsquo;s disease</strong> to<strong> increase the levels of acetylcholine</strong> in the <strong>brain,</strong> which helps in<strong> improving the cognitive symptoms </strong>of the<strong> disease.</strong></span></span></span></p>",
    "correct_choice_id": 13271,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3331,
    "choices": [
      {
        "id": 13303,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They act by increasing the concentration of Ach by preventing its degradation </span></span></p>"
      },
      {
        "id": 13304,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversible and irreversible anticholinesterases act by different mechanism of action </span></span></p>"
      },
      {
        "id": 13305,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticholinesterases act by binding to the anionic site of acetylcholinesterase </span></span></p>"
      },
      {
        "id": 13306,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All organophosphates anticholinesterases are water soluble</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding anticholinesterase?<strong> </strong></span></span></p>",
    "unique_key": "Q2140126",
    "question_audio": null,
    "question_video": null,
    "map_id": 35931,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) They act by increasing the concentration of Ach by preventing its degradation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterases</strong> inhibit the enzyme <strong>acetylcholinesterase, </strong>which is responsible for<strong> breaking down acetylcholine (ACh)</strong> in the <strong>synaptic cleft.</strong> By <strong>inhibiting this enzyme</strong>, <strong>anticholinesterases </strong>prevent the<strong> degradation of ACh</strong>, thus <strong>increasing its concentration</strong> and <strong>prolonging its action</strong> at the <strong>receptor sites.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Incorrect,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>reversible and irreversible anticholinesterases</strong> both <strong>inhibit acetylcholinesterase </strong>but <strong>differ </strong>mainly in the <strong>duration and strength of their binding </strong>to the enzyme. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Incorrect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, while there is an<strong> anionic site on the enzyme, </strong>the action of <strong>anticholinesterases </strong>is primarily through binding to the <strong>esteratic site</strong>, where they <strong>prevent the hydrolysis of ACh.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Option D. Incorrect,</strong> <strong>not </strong>all <strong>organophosphates are water-soluble;</strong> some are<strong> highly lipid-soluble,</strong> which allows them to <strong>cross lipid</strong> <strong>membranes</strong>, including the <strong>blood-brain barrier.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase</strong> drugs work by <strong>inhibiting the enzyme</strong> that <strong>breaks down acetylcholine,</strong> leading to<strong> increased levels of ACh.</strong> This has various therapeutic applications, such as treating<strong> myasthenia gravis, reversing neuromuscular blockade, </strong>and as an<strong> antidote for</strong> <strong>anticholinergic poisoning.</strong> Their<strong> ability to cross membranes</strong> and enter the<strong> CNS </strong>or the <strong>eye </strong>varies based on their <strong>molecular structure.</strong></span></span></span></p>",
    "correct_choice_id": 13303,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3335,
    "choices": [
      {
        "id": 13319,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
      },
      {
        "id": 13320,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ephedrine</span></span></span></p>"
      },
      {
        "id": 13321,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></p>"
      },
      {
        "id": 13322,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is associated with tachyphylaxis? </span></span></span></p>",
    "unique_key": "Q1225505",
    "question_audio": null,
    "question_video": null,
    "map_id": 35933,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ephedrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ephedrine </strong>is associated with <strong>tachyphylaxis,</strong> a phenomenon where <strong>repeated doses of a drug</strong> over a<strong> short period </strong>lead to a <strong>rapid</strong> <strong>decrease in the effect </strong>of that <strong>drug.</strong> <strong>Ephedrine, </strong>a <strong>sympathomimetic amine</strong>, stimulates <strong>both alpha and beta-adrenergic receptors,</strong> leading to<strong> increased heart rate, blood pressure, and bronchodilation.</strong> <strong>Tachyphylaxis</strong> to <strong>ephedrine </strong>occurs because its mechanism of action involves the <strong>indirect release of norepinephrine from nerve terminals,</strong> and with<strong> repeated use</strong>, the <strong>stores of norepinephrine</strong> can be <strong>depleted</strong>, leading to a<strong> diminished response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dopamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While dopamine can see a <strong>decrease in effectiveness over time,</strong> particularly in the context of <strong>long-term treatment</strong> for conditions like<strong> heart failure,</strong> it is <strong>not</strong> typically associated with <strong>rapid tachyphylaxis.</strong> <strong>Dopamine acts</strong> directly on<strong> dopamine receptors </strong>and<strong> indirectly on adrenergic receptor</strong>s to <strong>increase heart rate</strong> and <strong>blood pressure,</strong> among other effects.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Haloperidol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Haloperidol is an <strong>antipsychotic medication </strong>used to treat<strong> schizophrenia and acute psychosis</strong>. It works primarily by <strong>blocking dopamine receptors in the brain</strong>. <strong>Tachyphylaxis</strong> is <strong>not</strong> commonly associated with <strong>haloperidol or other antipsychotic medications.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Propranolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Propranolol is a <strong>beta-blocker </strong>used to manage<strong> hypertension, angina,</strong> and other conditions. It works by <strong>blocking beta-adrenergic receptors</strong>, <strong>reducing heart rate and blood pressure.</strong> T<strong>achyphylaxis</strong> is<strong> not </strong>a common issue with <strong>propranolol </strong>or most<strong> other beta-blockers.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> goal </strong>is to <strong>enhance</strong> understanding of<strong> pharmacodynamics,</strong> specifically the <strong>concept of tachyphylaxis, </strong>and to <strong>recognize which drugs</strong> are associated with this<strong> phenomenon.</strong> </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Examples of<strong> drugs acting </strong>by displacement include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyramine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ephedrine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudoephedrine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphetamines</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 13320,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3344,
    "choices": [
      {
        "id": 13355,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection</span></span></span></p>"
      },
      {
        "id": 13356,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation </span></span></span></p>"
      },
      {
        "id": 13357,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilation of bronchus </span></span></span></p>"
      },
      {
        "id": 13358,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased cardiac contractility </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation primarily causes which of the following actions?<strong> </strong></span></span></span></p>",
    "unique_key": "Q2413333",
    "question_audio": null,
    "question_video": null,
    "map_id": 35890,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Erection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The muscarinic receptors are a subset of acetylcholine receptors, which are stimulated by the neurotransmitter acetylcholine. Muscarinic receptors are associated with the parasympathetic nervous system, which is responsible for the &#39;rest and digest</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">functions of the body. Here&#39;s the explanation for each option:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation by the parasympathetic nervous system results in vasodilation and increased blood flow to erectile tissues, leading to an erection. This is an example of a cholinergic action where the neurotransmitter acetylcholine activates muscarinic receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ejaculation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is primarily a function of the sympathetic nervous system, not muscarinic receptor stimulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dilation of bronchus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation actually leads to bronchoconstriction, not dilation. The dilation of bronchi is mediated by the sympathetic nervous system through &beta;2-adrenergic receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increased cardiac contractility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is mainly mediated by &beta;1-adrenergic receptors under the influence of the sympathetic nervous system. Muscarinic receptor stimulation can decrease heart rate but does not directly increase contractility.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The parasympathetic nervous system, through muscarinic receptor stimulation, primarily causes erection due to vasodilation in erectile tissues, contrasting with the sympathetic nervous system&#39;s role in ejaculation.</span></span></span></p>",
    "correct_choice_id": 13355,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3277,
    "choices": [
      {
        "id": 13087,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha agonist</span></span></span></p>"
      },
      {
        "id": 13088,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></span></p>"
      },
      {
        "id": 13089,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 13090,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient present with diabetic macular edema with glaucoma. Which of the following drug should be avoided in this patient?</span></span></span></p>",
    "unique_key": "Q4795762",
    "question_audio": null,
    "question_video": null,
    "map_id": 35893,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues s</strong>hould be<strong> avoided in patients with diabetic macular edema </strong>because they can <strong>exacerbate</strong> the condition. These drugs, including <strong>Latanoprost and Bimatoprost, </strong>are known to <strong>potentially cause cystoid macular edema (CME)</strong>, which can <strong>worsen existing macular edema</strong> in<strong> diabetic patients. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha agonists: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These are<strong> not primarily </strong>associated with<strong> exacerbation of macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;A<strong> carbonic anhydrase inhibitor, not </strong>typically associated with <strong>causing or worsening macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Commonly used in glaucoma</strong> to <strong>reduce intraocular pressure</strong> without affecting macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues </strong>can <strong>worsen macular edema</strong> and therefore should be <strong>avoided in patients with diabetic macular edema. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important<strong> adverse effects of anti-glaucoma drugs</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115656.jpg\" style=\"height:720px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8<sup>th</sup>/169</span></strong></span></span></p>",
    "correct_choice_id": 13090,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3282,
    "choices": [
      {
        "id": 13107,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
      },
      {
        "id": 13108,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noradrenaline</span></span></span></p>"
      },
      {
        "id": 13109,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
      },
      {
        "id": 13110,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following acts on &alpha;1, &alpha;2 and &beta;1 receptors but does not stimulate &beta;2 receptors?</span></span></span></p>",
    "unique_key": "Q7687229",
    "question_audio": null,
    "question_video": null,
    "map_id": 35895,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Noradrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline (norepinephrine) acts on &alpha;1, &alpha;2, and &beta;1 adrenergic receptors.</strong> It is a naturally occurring <strong>catecholamine </strong>that functions as a<strong> neurotransmitter and hormone in the body</strong>. Noradrenaline&#39;s action on <strong>&alpha;1 and &alpha;2 receptors</strong> is responsible for its <strong>vasoconstrictive effects</strong>, while its action on <strong>&beta;1 receptors</strong> affects <strong>cardiac output by increasing the heart rate </strong>and <strong>myocardial</strong> <strong>contractility.</strong> It <strong>does not stimulate &beta;2 receptors</strong>, which are primarily involved in <strong>bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg\" style=\"height:338px; width:1000px\" /></span></u></strong></span></span></p>",
    "correct_choice_id": 13108,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3302,
    "choices": [
      {
        "id": 13187,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation by beta-2 receptors</span></span></span></p>"
      },
      {
        "id": 13188,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiovascular effects of beta-1 receptors</span></span></span></p>"
      },
      {
        "id": 13189,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on blood vessels by alpha-1 receptors</span></span></span></p>"
      },
      {
        "id": 13190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on presynaptic alpha-2 receptors</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of anaphylactic shock, which of the following action of adrenaline is not required? </span></span></p>",
    "unique_key": "Q5649357",
    "question_audio": null,
    "question_video": null,
    "map_id": 35902,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Action on presynaptic alpha-2 receptors</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline (epinephrine)</strong> is the drug of choice for the treatment of <strong>anaphylactic shock</strong>, primarily due to its effects on<strong> alpha-1, beta-1, and beta-2 adrenergic receptors. </strong>These actions include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-1 receptor</strong> stimulation, which causes <strong>vasoconstriction,</strong> critical for <strong>increasing blood pressure</strong> during the <strong>hypotensive </strong>state of <strong>anaphylactic shock.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-1 receptor</strong> stimulation, which leads to <strong>increased cardiac output</strong>, providing necessary<strong> cardiovascular support.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 receptor</strong> stimulation, essential for <strong>reversing bronchoconstriction</strong> and easing breathing in patients experiencing <strong>anaphylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The action on <strong>presynaptic alpha-2 receptors</strong> is <strong>not</strong> beneficial in <strong>anaphylactic shock.</strong> <strong>Alpha-2 receptors </strong>typically function to inhibit the release of <strong>norepinephrine (noradrenaline), </strong>acting as a<strong> negative feedback mechanism</strong>. In the setting of anaphylactic shock, <strong>inhibition of neurotransmitter </strong>release is<strong> counterproductive</strong>, as<strong> maximal sympathetic stimulation</strong> is required to counter the effects of <strong>anaphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchodilation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> beta-2 receptors </strong>is vital for reversing <strong>airway constriction </strong>in <strong>anaphylaxis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cardiovascular</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> effects of<strong> beta-1 receptors </strong>are crucial for supporting <strong>heart function during shock</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vasoconstriction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> alpha-1 receptors </strong>is necessary to<strong> counteract </strong>the profound <strong>vasodilation and hypotension</strong> seen in <strong>anaphylactic shock.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presynaptic alpha-2 receptor</strong> action of <strong>adrenaline,</strong> which would normally <strong>inhibit norepinephrine</strong> release and <strong>dampen</strong> <strong>sympathetic responses</strong>, is <strong>not </strong>desired in the treatment of <strong>anaphylactic shock</strong>, where a <strong>strong sympathetic </strong>response is needed to combat severe <strong>allergic reactions.</strong></span></span></span></p>",
    "correct_choice_id": 13190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3313,
    "choices": [
      {
        "id": 13231,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
      },
      {
        "id": 13232,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride</span></span></span></p>"
      },
      {
        "id": 13233,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></span></p>"
      },
      {
        "id": 13234,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testosterone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man came with urinary symptoms of increased frequency and hesitation. The patient was diagnosed with benign hyperplasia of prostate. Which of the drugs will help to prevent further growth and possibly reduces the size of the prostate? </span></span></span></p>",
    "unique_key": "Q1397598",
    "question_audio": null,
    "question_video": null,
    "map_id": 35903,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Finasteride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride is a <strong>5-alpha reductase inhibitor </strong>that reduces the conversion of <strong>testosterone to dihydrotestosterone (DHT)</strong>, which is a <strong>more potent androgen</strong> in the <strong>prostate gland</strong>. By<strong> lowering the levels of DHT, </strong>finasteride can prevent further <strong>growth of the prostate</strong> and potentially <strong>reduce its size.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tamsulosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This medication is an <strong>alpha-1A antagonist</strong> that <strong>relaxes the muscles </strong>in the<strong> prostate and bladder neck,</strong> <strong>improving urine flow,</strong> but<strong> does not</strong> affect<strong> prostate size. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prazosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; While this <strong>non-selective alpha-1 antagonist</strong> can improve symptoms of<strong> benign prostatic hyperplasia (BPH</strong>) by <strong>relaxing prostate and bladder neck muscles, </strong>it <strong>doesn&#39;t reduce prostate size </strong>and is noted for <strong>causing postural hypotension. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Testosterone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Administration of testosterone can actually <strong>exacerbate BPH</strong> due to its <strong>conversion to DHT </strong>within the <strong>prostate, </strong>leading to<strong> further growth.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient diagnosed with <strong>BPH, finasteride </strong>is the <strong>drug of choice</strong> to not only <strong>alleviate urinary symptoms</strong> but also potentially <strong>reduce prostate size</strong> due to its mechanism of<strong> inhibiting the enzyme 5-alpha reductase</strong> and <strong>lowering intraprostatic DHT levels.</strong></span></span></span></p>",
    "correct_choice_id": 13232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3291,
    "choices": [
      {
        "id": 13143,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin</span></span></span></p>"
      },
      {
        "id": 13144,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine</span></span></span></p>"
      },
      {
        "id": 13145,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
      },
      {
        "id": 13146,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following alpha-blocker drugs is used in the treatment of benign hypertrophy of the prostate without producing significant hypotension?</span></span></span></p>",
    "unique_key": "Q5843975",
    "question_audio": null,
    "question_video": null,
    "map_id": 35896,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Tamsulosin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin </strong>is <strong>an alpha-1 receptor blocker </strong>with <strong>selectivity for the alpha-1A receptors</strong>, which are primarily located in the <strong>prostate</strong> <strong>and bladder neck.</strong> This <strong>selectivity </strong>allows <strong>tamsulosin to relax the smooth muscle </strong>in these areas, <strong>improving urinary flow </strong>and symptoms associated with <strong>benign prostatic hypertrophy (BPH) </strong>without significantly affecting <strong>vascular smooth muscle tone </strong>and thus <strong>minimizing </strong>the risk of <strong>hypotension</strong>. This characteristic makes<strong> tamsulosin </strong>particularly <strong>suitable </strong>for the treatment of<strong> BPH</strong>, providing <strong>symptomatic relief </strong>with a <strong>lower risk of cardiovascular side effects </strong>compared to <strong>non-selective alpha-blockers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin is a<strong> non-selective alpha-1 antagonist. </strong>It is used to treat <strong>hypertension and BPH</strong>, but it <strong>does not </strong>have the same degree of selectivity for the<strong> alpha-1A receptors as tamsulosin </strong>and can cause more<strong> pronounced hypotension </strong>as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Phentolamine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine is a<strong> non-selective alpha-adrenergic antagonist</strong>, blocking both<strong> alpha-1 and alpha-2 receptors. </strong>It is primarily used in the management of<strong> hypertensive emergencies </strong>related to<strong> pheochromocytoma </strong>and is<strong> not </strong>commonly used in the treatment of <strong>BPH</strong>. Due to its <strong>non-selectivity, </strong>it can cause significant <strong>hypotension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Terazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin is another<strong> non-selective alpha-1 antagonist </strong>used to treat <strong>hypertension and symptoms of BPH</strong>. While it is effective in <strong>relieving urinary symptoms </strong>related to <strong>BPH,</strong> its<strong> non-selective</strong> action on<strong> alpha-1 receptors </strong>can also lead to more <strong>pronounced hypotension </strong>compared to <strong>tamsulosin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong><u> </u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin,</strong> with its selectivity for <strong>alpha-1A receptors,</strong> is preferable for treating <strong>BPH symptoms</strong> as it <strong>minimizes </strong>the risk of <strong>hypotension</strong>. In contrast, <strong>non-selective alpha-blockers </strong>like<strong> doxazosin, terazosin, and phentolamine </strong>can be used in <strong>BPH </strong>but may have a<strong> higher risk </strong>of causing <strong>hypotension</strong>. </span></span></span></p>",
    "correct_choice_id": 13145,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3273,
    "choices": [
      {
        "id": 13071,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis</span></span></span></p>"
      },
      {
        "id": 13072,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinic actions of acetylcholine</span></span></span></p>"
      },
      {
        "id": 13073,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biphasic response of adrenaline</span></span></span></p>"
      },
      {
        "id": 13074,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasomotor reversal of Dale</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeated administration of a drug produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture1.jpg\" style=\"height:160px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2060792",
    "question_audio": null,
    "question_video": null,
    "map_id": 35892,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tachyphylaxis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a <strong>blood pressure tracing of a dog</strong>, with repeated administrations of a <strong>drug indicated by &#39;T&#39; (for Tyramine 0.3 mg/kg). </strong>The tracing shows<strong> successive spikes in blood pressure </strong>following each <strong>administration of the drug</strong>, with the<strong> magnitude of the spikes appearing to diminish over time</strong>. This <strong>phenomenon </strong>is known as <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachyphylaxis </strong>refers to a <strong>rapidly decreasing response </strong>to a drug following its <strong>initial administration</strong>. In the context of the <strong>blood pressure tracing </strong>provided, it appears that the<strong> initial doses of Tyramine </strong>produce significant <strong>increases in blood pressure</strong>, but as <strong>more doses are administered, </strong>the effect becomes <strong>less pronounced. </strong>This is a classic characteristic of<strong> tachyphylaxis, </strong>where the <strong>body&#39;s response to a drug diminishes </strong>with <strong>repeated dosing over a short period.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Nicotinic actions of acetylcholine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is<strong> not </strong>the <strong>correct answer</strong>. The<strong> nicotinic actions</strong> of <strong>acetylcholine </strong>refer to the effect acetylcholine has on<strong> nicotinic acetylcholine</strong> <strong>receptors,</strong> which are<strong> ligand-gated ion channels</strong> found in the <strong>nervous system and at the neuromuscular junction</strong>. Normally <strong>acetylcholine decreases blood pressure and heart rate </strong>due to its action of <strong>muscarinic receptors. </strong>However, if we give <strong>very high dose of acetylcholine </strong>after giving <strong>atropine (to block muscarinic receptors), </strong>then it shows <strong>increase in BP and heart rate</strong>. This is due to the action of <strong>acetylcholine on nicotinic receptors</strong> present on <strong>ganglia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Biphasic response of adrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is<strong> incorrect. </strong>A <strong>biphasic response </strong>to<strong> adrenaline </strong>would involve an <strong>initial phase </strong>in which there is <strong>increase in blood pressure (due to stimulation of alpha 1 receptors) </strong>followed by a <strong>second phase </strong>in which there is fall in <strong>blood pressure (due to action on beta 2 receptors). </strong>The <strong>tracing does not </strong>show a <strong>biphasic response; </strong>it shows a <strong>series of responses </strong>that <strong>diminish over time, consistent </strong>with <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vasomotor reversal of Dale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vasomotor reversal of Dale </strong>is a phenomenon where <strong>adrenaline </strong>can produce a <strong>paradoxical decrease in blood pressure </strong>due to <strong>stimulation of vasodilatory beta-adrenergic receptors</strong>, especially after <strong>pre-treatment with drugs </strong>that <strong>block alpha-adrenergic receptors. </strong>This is <strong>not </strong>what is depicted in the tracing.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the image, the correct answer is:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis is&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a <strong>diminishing response </strong>to <strong>repeated administrations </strong>of the same dose of a drug over a short period. This is a common pharmacological phenomenon often seen with drugs that<strong> act on receptors or other cellular targets </strong>that can become <strong>desensitized or down-regulated with frequent stimulation</strong>.</span></span></p>",
    "correct_choice_id": 13071,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 3340,
    "choices": [
      {
        "id": 13339,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albuterol</span></span></span></p>"
      },
      {
        "id": 13340,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
      },
      {
        "id": 13341,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></span></span></p>"
      },
      {
        "id": 13342,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudoephedrine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 66-year-old woman with a long history of heavy smoking presents to her doctor with complaints of shortness of breath and chronic coughing that has been present for about 2 years and has been worsening in frequency. The doctor decides to prescribe a bronchodilator agent that has minimal cardiac side effects, since the patient also has an extensive cardiac history. Which medication did the doctor likely prescribe? </span></span></span></p>",
    "unique_key": "Q6319845",
    "question_audio": null,
    "question_video": null,
    "map_id": 35889,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ipratropium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this scenario, the patient presents with symptoms consistent with <strong>chronic obstructive pulmonary disease (COPD),</strong> a common condition in<strong> long-term smokers.</strong> The doctor&#39;s decision to prescribe a<strong> bronchodilator with minimal cardiac side effects, </strong>given the <strong>patient&#39;s extensive cardiac history,</strong> points towards<strong> Ipratropium.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticholinergic bronchodilator</strong> used in the <strong>management of COPD and asthma.</strong> It works by<strong> blocking</strong> <strong>muscarinic receptors </strong>in the<strong> airways, </strong>leading to<strong> bronchodilation.</strong> Importantly, it has<strong> minimal systemic absorption,</strong> which results in <strong>fewer cardiac side effects</strong> compared to <strong>other bronchodilators</strong> that act on <strong>beta-adrenergic receptor</strong>s. This makes it a <strong>suitable choice for patients</strong> with underlying <strong>cardiac conditions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Albuterol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Albuterol is a<strong> beta-2 agonist </strong>that effectively <strong>relieves bronchoconstriction.</strong> However, it can have <strong>cardiac side effects </strong>such as <strong>tachycardia and palpitations</strong>, especially in patients with <strong>existing cardiac conditions,</strong> due to its <strong>slight action on beta-1 adrenergic receptors.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Atenolol is a<strong> beta-1 selective blocker</strong> used primarily in the treatment of<strong> hypertension </strong>and other <strong>cardiovascular conditions</strong>. It is <strong>not a bronchodilator</strong> and would not be appropriate for the<strong> treatment of COPD or asthma.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pseudoephedrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pseudoephedrine is a <strong>sympathomimetic drug </strong>used as a <strong>decongestant.</strong> It can<strong> increase</strong> <strong>blood pressure </strong>and <strong>heart rate, </strong>making it <strong>unsuitable</strong> for a patient with an <strong>extensive cardiac history</strong> requiring <strong>bronchodilation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>selection of bronchodilators </strong>in the management of <strong>respiratory conditions like COPD, </strong>especially in patients with <strong>comorbid cardiac conditions.</strong> Recognizing the <strong>pharmacological profiles</strong> of <strong>different classes of bronchodilators </strong>and their <strong>systemic effects</strong> is crucial for <strong>minimizing adverse effects </strong>and <strong>optimizing patient care.</strong></span></span></span></p>",
    "correct_choice_id": 13341,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3333,
    "choices": [
      {
        "id": 13311,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angina</span></span></span></p>"
      },
      {
        "id": 13312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial atrioventricular block</span></span></span></p>"
      },
      {
        "id": 13313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic hypertrophic subaortic cardiomyopathy</span></span></span></p>"
      },
      {
        "id": 13314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial tremor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol is useful in the treatment of all of the following EXCEPT? </span></span></span></p>",
    "unique_key": "Q2019229",
    "question_audio": null,
    "question_video": null,
    "map_id": 35888,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Partial atrioventricular block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is a <strong>non-selective beta blocker</strong>, which means it can <strong>block beta-1 and beta-2 adrenergic receptors.</strong> It is used in various <strong>cardiovascular and non-cardiovascular</strong> conditions due to <strong>its ability to slow heart rate,</strong> <strong>decrease myocardial oxygen demand, </strong>and <strong>reduce tremors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated </strong>in patients with<strong> partial atrioventricular block </strong>as it can exacerbate the condition leading to <strong>complete heart block</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Angina:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>is used in the management of<strong> angina pectoris</strong> due to its <strong>ability to reduce myocardial oxygen demand</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>hypertrophic subaortic cardiomyopathy (HOCM):</strong> Beta blockers like <strong>propranolol </strong>are used in<strong> HOCM to reduce</strong> the <strong>outflow obstruction </strong>and <strong>improve symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial tremor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Propranolol</strong> is effective in<strong> reducing tremors </strong>in conditions like<strong> familial or essential tremor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is <strong>contraindicated</strong> in patients with<strong> partial atrioventricular block </strong>as it can <strong>exacerbate the condition </strong>leading to <strong>complete</strong> <strong>heart block.</strong> It is, however, <strong>beneficial</strong> in conditions such as<strong> angina, HOCM, and familial tremors</strong>. Patients with <strong>variant angina</strong> <strong>(Prinzmetal&#39;s angina)</strong> <strong>should not&nbsp;</strong>&nbsp;be treated with <strong>propranolol due to the risk of coronary vasospasm.</strong></span></span></p>",
    "correct_choice_id": 13312,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3301,
    "choices": [
      {
        "id": 13183,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      },
      {
        "id": 13184,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopexamine</span></span></span></p>"
      },
      {
        "id": 13185,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
      },
      {
        "id": 13186,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a catecholamine, that can stimulate D1, D2, alpha 1 and &beta;-1 receptors, but not &beta;-2 receptors? </span></span></p>",
    "unique_key": "Q1403857",
    "question_audio": null,
    "question_video": null,
    "map_id": 35901,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dopamine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is a<strong> catecholamine neurotransmitter and hormone </strong>that exhibits activity on<strong> both dopaminergic and adrenergic receptors.</strong> It specifically<strong> stimulates D1 and D2 dopamine receptors</strong>, which are primarily involved in <strong>neurological functions </strong>and <strong>renal vasodilation</strong>, and <strong>&alpha;1 and &beta;1 adrenergic receptors,</strong> which mediate <strong>vasoconstriction and increase heart rate and contractility,</strong> respectively. Importantly, <strong>dopamine does not </strong>act on <strong>&beta;2 adrenergic receptors, </strong>which are mainly responsible for<strong> bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121213.jpg\" style=\"height:435px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong><u>&nbsp;</u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is the <strong>catecholamine</strong> that meets the criteria of stimulating <strong>D1, D2, &alpha;1, and &beta;1 receptors </strong>without affecting <strong>&beta;2 receptors</strong>, which is particularly relevant in treating certain <strong>cardiovascular conditions</strong> where <strong>selective receptor </strong>activation is <strong>desired</strong></span></span></span></p>",
    "correct_choice_id": 13185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 3320,
    "choices": [
      {
        "id": 13259,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></p>"
      },
      {
        "id": 13260,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinine </span></span></p>"
      },
      {
        "id": 13261,
        "text": "<p style=\"margin-right:-1px\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine </span></span></p>"
      },
      {
        "id": 13262,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated, and skin was dry. Body temperature is raised, and heart rate is high. These signs and symptoms can occur with the intake of which of the following substance?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture3_XXE4pf8.jpg\" style=\"height:182px; width:300px\" /></span></span></p>",
    "unique_key": "Q5170375",
    "question_audio": null,
    "question_video": null,
    "map_id": 35906,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Atropine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>signs and symptoms</strong> described are characteristic of <strong>atropine poisoning,</strong> which include <strong>dilated pupils (mydriasis), dry skin,</strong> <strong>elevated body temperature (hyperthermia), and tachycardia.</strong> The <strong>plant </strong>identified as the <strong>source of atropine</strong> in this case is <strong>Datura</strong> <strong>stramonium.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Morphine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> as morphine typically causes <strong>constricted pupils (miosis), </strong>not dilation. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Quinine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect,</strong> as quinine is <strong>not</strong> commonly associated with <strong>these symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Digoxin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect, </strong>as <strong>digoxin overdose</strong> typically <strong>does not cause hyperthermia</strong> and <strong>dry skin</strong> but can cause other symptoms such as <strong>nausea, vomiting, and heart rhythm disturbances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> DHATURA acronym</strong> can be used to remember the<strong> signs of atropine poisoning: Dry mouth and Delirium, Hyperthermia, Agitation, Tachycardia, Urinary retention, Retention of stool, and lost Accommodation (dilated pupils, photophobia, blurred vision).</strong></span></span></span></p>",
    "correct_choice_id": 13261,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 3278,
    "choices": [
      {
        "id": 13091,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By decreasing the rate of diastolic depolarization of SA node</span></span></span></p>"
      },
      {
        "id": 13092,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By causing delay through AV node</span></span></span></p>"
      },
      {
        "id": 13093,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By blocking calcium channels and prolonging the plateau phase</span></span></span></p>"
      },
      {
        "id": 13094,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By reducing the rate of ventricular repolarization</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine decrease heart rate by which of the following mechanisms?</span></span></span></p>",
    "unique_key": "Q8824422",
    "question_audio": null,
    "question_video": null,
    "map_id": 35894,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) By decreasing the rate of diastolic depolarization of SA node</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetylcholine, </strong>when acting on the<strong> heart, </strong>primarily affects the<strong> muscarinic receptors. </strong>The effect of <strong>acetylcholine on heart rate</strong> is known as the<strong> parasympathetic or vagal effect</strong>, which <strong>slows the heart rate</strong>. Spontaneous d<strong>iastolic depolarization (Phase 4 of action</strong> <strong>potential) of sinoatrial (SA) node</strong> is required for a<strong>utomaticity of SA node. </strong>Acetylcholine acts on the node to <strong>decrease the slope of phase 4</strong>. This action slows the <strong>rate of spontaneous depolarization </strong>and,<strong> consequently, decreases the heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By<strong> decreasing the rate </strong>of <strong>diastolic depolarization of SA node</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This action on the <strong>SA node slows the pacemaker activity,</strong> thereby <strong>decreasing the heart rate,</strong> which is the primary mechanism by which <strong>acetylcholine </strong>exerts its<strong> negative chronotropic effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. By causing delay through AV node:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>While acetylcholine</strong> does cause a <strong>delay in conduction </strong>through the <strong>atrioventricular (AV) node, </strong>this is<strong> not</strong> the primary mechanism by which it<strong> decreases the heart rate.</strong> However, this effect can contribute to a <strong>reduction in the ventricular rate</strong>, especially during conditions such as <strong>atrial fibrillation,</strong> by <strong>limiting the number of impulses t</strong>hat reach the<strong> ventricles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. By blocking calcium channels and prolonging the plateau phase:</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>option is incorrect </strong>with respect to<strong> heart rate</strong>. <strong>Blocking calcium channels</strong> and <strong>prolonging the plateau phase</strong> of the<strong> cardiac action potential </strong>would affect the<strong> force of cardiac muscle</strong> <strong>contraction </strong>and potentially the <strong>duration of the action potential,</strong> but it is <strong>not </strong>the primary mechanism by which<strong> acetylcholine decreases heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. By reducing the rate of ventricular repolarization:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This mechanism is <strong>not </strong>associated with <strong>acetylcholine</strong>. Acetylcholine <strong>does not </strong>typically <strong>reduce the rate of ventricular repolarization; </strong>instead, it would affect the <strong>repolarization phase of the atria more </strong>than the <strong>ventricles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aetylcholine decreases heart rate</strong> by <strong>decreasing the rate of diastolic depolarization of the SA node</strong>, which <strong>reduces </strong>the frequency of <strong>action potentials generated </strong>and hence<strong> lowers the heart rate</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8th/114</span></strong></span></span></p>",
    "correct_choice_id": 13091,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 3292,
    "choices": [
      {
        "id": 13147,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propranolol</span></span></span></p>"
      },
      {
        "id": 13148,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Timolol</span></span></span></p>"
      },
      {
        "id": 13149,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Betaxolol</span></span></span></p>"
      },
      {
        "id": 13150,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Levobunolol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following beta-blockers can be used in glaucoma except? </span></span></span></p>",
    "unique_key": "Q2468688",
    "question_audio": null,
    "question_video": null,
    "map_id": 35897,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) &nbsp;Propranolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta blockers </strong>with <strong>membrane stabilizing property </strong>should be<strong> avoided in glaucoma</strong>.</span></em></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is a <strong>non-selective beta-adrenergic receptor blocker </strong>widely used for its<strong> cardiovascular effects</strong>, such as treating <strong>hypertension, angina pectoris, </strong>and certain types of <strong>arrhythmias</strong>. Unlike the<strong> beta-blockers </strong>commonly employed in the treatment of <strong>glaucoma,</strong> <strong>propranolol lacks the specific ocular advantages </strong>provided by others, notably<strong> its absence in the standard management of glaucoma. </strong>A critical distinction is its<strong> membrane-stabilizing activity, </strong>which can lead to<strong> corneal anesthesia, </strong>making it <strong>less suitable </strong>for <strong>ocular applications</strong>. This property can potentially interfere with <strong>corneal health by reducing its sensitivity</strong>, thereby<strong> increasing the risk </strong>of <strong>corneal injuries </strong>going unnoticed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Timolol:</strong> Timolol is a <strong>non-selective beta-blocker</strong> effectively used in <strong>glaucoma</strong> treatment by <strong>lowering intraocular pressure</strong> through <strong>decreased aqueous humor production</strong>. <strong>Unlike propranolol,</strong> <strong>timolol </strong>is preferred for<strong> ocular use </strong>due to its <strong>minimal systemic</strong> <strong>side effects</strong> and<strong> lack of significant membrane-stabilizing activity</strong> that could lead to <strong>corneal anesthesia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betaxolol: </strong>&nbsp;Betaxolol is a <strong>beta-1 selective adrenergic receptor blocker</strong>. Its selectivity is <strong>beneficial </strong>in patients with <strong>respiratory issues, </strong>as it minimally affects <strong>beta-2 receptors associated with bronchial smooth muscle</strong>. <strong>Betaxolol </strong>is used in<strong> glaucoma</strong> treatment to <strong>reduce intraocular pressure</strong> and is noted for having<strong> less membrane-stabilizing activity </strong>compared to <strong>non-selective beta-blockers</strong>, making it safer for the cornea.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Levobunolol:</strong> Levobunolol is another <strong>non-selective beta-blocker </strong>used for<strong> <em>lowering intraocular pressure </em>in glaucoma</strong> patients. It shares <strong>similar benefits with timolol</strong> in terms of <strong>efficacy </strong>in glaucoma treatment and has a l<strong>ow risk of causing corneal</strong> <strong>anesthesia </strong>due to its <strong>minimal membrane-stabilizing effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> timolol, betaxolol, and levobunolol </strong>are suitable to be used in <strong>glaucoma </strong>due to their specific <strong>ocular effects </strong>and <strong>minimal membrane-stabilizing activity</strong>, <strong>propranolol </strong>is <strong>not </strong>commonly used in<strong> glaucoma </strong>due to its <strong>non-selective action </strong>and <strong>potential </strong>for causing <strong>corneal anesthesia</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-blockers with Membrane Stabilizing Activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs possess Na+ channel blocking (local anesthetic) activity. It can contribute to anti-arrhythmic action.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs should be avoided in glaucoma due to the risk of corneal anesthesia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Examples</strong>: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ossess:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>P</strong>ropranolol (maximum)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Me</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">mbrane stabilizing or: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Me</strong>toprolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ocal: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<strong>L</strong>abetalol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">naesthetic: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<strong>A</strong>cebutolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">roperty: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<strong>P</strong>indolol</span></span></span></p>",
    "correct_choice_id": 13147,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3293,
    "choices": [
      {
        "id": 13151,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less bronchoconstriction</span></span></span></p>"
      },
      {
        "id": 13152,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less adverse effect on lipid profile</span></span></span></p>"
      },
      {
        "id": 13153,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less likely to cause glucose intolerance</span></span></span></p>"
      },
      {
        "id": 13154,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Properties making cardio-selective beta-blockers desirable are?</span></span></p>",
    "unique_key": "Q4150061",
    "question_audio": null,
    "question_video": null,
    "map_id": 35898,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardio-selective beta-blockers,</strong> also known as <strong>beta-1 selective blockers,</strong> are designed to preferentially <strong>block beta-1 adrenergic</strong> <strong>receptors </strong>located primarily in the <strong>heart. </strong>This specificity confers several advantages in clinical use, including:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less bronchoconstriction:&nbsp;</strong>By selectively targeting <strong>beta-1 receptors and sparing beta-2 receptors </strong>(which<strong> mediate bronchial smooth muscle relaxation), cardio-selective beta-blockers</strong> <strong>reduce </strong>the risk of <strong>bronchoconstriction</strong>. This makes them a safer option for patients with respiratory conditions such as <strong>asthma or chronic obstructive pulmonary disease (COPD).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less adverse effect on lipid profile:&nbsp;Cardio-selective beta-blockers</strong> are less likely to <strong>negatively impact lipid metabolism. Non-selective beta-blockers </strong>can <strong>increase triglycerides and decrease HDL cholesterol</strong>. <strong>Cardio-selective </strong>agents have a lesser effect on these parameters, making them a preferable <strong>choice for patients </strong>with or at <strong>risk for metabolic syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less likely to cause glucose intolerance:&nbsp;Non-selective beta-blockers</strong> can <strong>impair insulin sensitivity </strong>and mask symptoms of <strong>hypoglycemia,</strong> which is a concern for <strong>diabetic patients</strong>. <strong>Cardio-selective beta-blockers </strong>have a <strong>reduced impact on glucose metabolism </strong>and are, therefore, considered a better option for patients with <strong>diabetes </strong>or those at <strong>risk for glucose intolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The benefits of <strong>cardio-selective beta-blockers </strong>over<strong> non-selective beta-blockers </strong>include: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lower propensity</strong> to cause <strong>bronchoconstriction.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less interference</strong> with<strong> carbohydrate metabolism</strong> and <strong>safer in diabetes mellitus. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less chances</strong> of precipitating<strong> Raynaud&rsquo;s phenomenon.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>No deleterious effect</strong> on <strong>blood lipid profile.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ineffective</strong> in <strong>suppressing essential tremor</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less liable</strong> to<strong> impair exercise capacity.</strong></span></span></li>\r\n</ul>",
    "correct_choice_id": 13154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3296,
    "choices": [
      {
        "id": 13163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylalanine hydroxylase</span></span></span></p>"
      },
      {
        "id": 13164,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine hydroxylase</span></span></span></p>"
      },
      {
        "id": 13165,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopa Decarboxylase</span></span></span></p>"
      },
      {
        "id": 13166,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine &beta; hydroxylase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rate limiting step in catecholamine synthesis is?</span></span></p>",
    "unique_key": "Q3332473",
    "question_audio": null,
    "question_video": null,
    "map_id": 35899,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Ans. B) Tyrosine hydroxylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Catecholamine synthesis </strong>involves several <strong>enzymatic </strong>steps, starting from the <strong>amino acid tyrosine</strong>. The<strong> rate-limiting step </strong>of this pathway is the <strong>hydroxylation of tyrosine </strong>to form <strong>dihydroxyphenylalanine (DOPA), </strong>which is <strong>catalyzed </strong>by the enzyme <strong>tyrosine hydroxylase</strong>. This <strong>enzyme&#39;s activity </strong>is the primary control point for the <strong>production of catecholamines</strong>, which include <strong>dopamine, norepinephrine, and epinephrine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synthesis Pathway:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosine </strong>is <strong>hydroxylated by tyrosine hydroxylase </strong>in the presence of<strong> tetrahydrobiopterin (THB) </strong>to form <strong>DOPA</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>DOPA </strong>is then <strong>decarboxylated by DOPA decarboxylase</strong>, which requires<strong> vitamin B6</strong>, to form<strong> dopamine</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine </strong>is converted to <strong>norepinephrine </strong>by<strong> dopamine &beta; hydroxylase</strong>, with<strong> vitamin C </strong>as a <strong>cofactor.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine</strong> is further <strong>methylated </strong>to form<strong> epinephrine </strong>in the <strong>adrenal medulla by phenylethanolamine N-methyltransferase</strong>, which uses <strong>S-adenosyl methionine </strong>as a<strong> methyl donor.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Phenylalanine hydroxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Not the rate-limiting </strong>step in <strong>catecholamine synthesis,</strong> but it is involved in the <strong>conversion of</strong> <strong>phenylalanine to tyrosine. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dopa Decarboxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Catalyzes the conversion of DOPA to dopamine </strong>but is not the rate-limiting step. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Dopamine &beta; hydroxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Converts dopamine to norepinephrine,</strong> not the rate-limiting step in catecholamine synthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosine hydroxylase </strong>is the<strong> rate-limiting enzyme </strong>in the synthesis of<strong> catecholamines</strong>, determining the <strong>overall rate </strong>at which these critical <strong>neurotransmitters and hormones</strong> are produced in the body.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture21_jXwtz1W.jpg\" style=\"height:663px; width:400px\" /></span></span></span></p>",
    "correct_choice_id": 13164,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3299,
    "choices": [
      {
        "id": 13175,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></p>"
      },
      {
        "id": 13176,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine</span></span></span></p>"
      },
      {
        "id": 13177,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
      },
      {
        "id": 13178,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs acting on dilator pupillae has an action analogous to that of pilocarpine on sphincter pupillae?</span></span></span></p>",
    "unique_key": "Q4086012",
    "question_audio": null,
    "question_video": null,
    "map_id": 35900,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Phenylephrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the Question:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphincter pupillae contains M3 receptors</strong>, <strong>pilocarpine stimulate </strong>these <strong>receptors</strong> and result in <strong>miosis</strong>. Therefore, action of <strong>pilocarpine of sphincter pupillae </strong>is to stimulate it. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Analogous</strong> means <strong>functionally similar</strong>. So <strong>analogous action on dilator pupillae</strong> means to stimulate<strong> dilator pupillae.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, the question is that which drug stimulate dilator pupillae.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concept:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphincter pupillae contains M3 receptors</strong>. Thus, <strong>cholinergic drugs </strong>like <strong>pilocarpine, physostigmine </strong>etc <strong>stimulate </strong>these <strong>receptors </strong>resulting in <strong>miosis</strong>. This is called <strong>active miosis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dilator pupillae </strong>contains<strong> Alpha 1 receptors</strong>. Thus, <strong>adrenergic </strong>drugs like <strong>epinephrine, phenylephrine etc</strong>. <strong>stimulate </strong>these receptors resulting in<strong> mydriasis</strong>. This is called <strong>active mydriasis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>M3 blockers </strong>like<strong> atropine</strong>, <strong>tropicamide </strong>etc cause <strong>unopposed </strong>stimulation of <strong>dilator pupillae </strong>resulting in <strong>passive mydriasis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha 1 blockers</strong> may result in<strong> unopposed stimulation of sphincter pupillae </strong>leading to <strong>passive miosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>sympathomimetic drug</strong> that acts as an <strong>alpha-adrenergic agonis</strong>t. When applied <strong>topically </strong>to the eye, it <strong>stimulates the dilator pupillae muscle</strong>, causing <strong>pupillary dilation (mydriasis)</strong>. This action is <strong>analogous </strong>to that of <strong>pilocarpine on the sphincter pupillae</strong>.<strong> Pilocarpine</strong> is a<strong> cholinergic agonist</strong> that contracts the <strong>sphincter pupillae muscle,</strong> resulting in <strong>pupillary constriction (miosis).</strong> <strong>Both drugs </strong>have direct actions on their <strong>respective target muscles in the iris,</strong> but they produce <strong>opposite effects: phenylephrine causes dilation</strong>, while <strong>pilocarpine causes constriction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Timolol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol is a n<strong>on-selective beta-adrenergic receptor blocker</strong> used in the treatment of <strong>glaucoma to lower</strong> <strong>intraocular pressure. </strong>It <strong>does not</strong> have a direct effect on the <strong>muscles of the iris </strong>and thus <strong>does not cause analogous action</strong> to <strong>pilocarpine on sphincter pupillae.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neostigmine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine is a <strong>cholinesterase inhibitor </strong>that<strong> increases the concentration of acetylcholine</strong> at <strong>cholinergic</strong> <strong>synapses</strong>, indirectly causing <strong>miosis</strong> by enhancing the effect of <strong>acetylcholine on the sphincter pupillae</strong>. Its mechanism of action is indirect, unlike the <strong>direct action of phenylephrine on the dilator pupillae.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tropicamide:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide is an <strong>anticholinergic agent </strong>used as a <strong>mydriatic to dilate the pupil.</strong> It works by <strong>blocking</strong> <strong>muscarinic receptors </strong>in the <strong>sphincter pupillae, preventing acetylcholine from contracting the muscle</strong>. While tropicamide does cause <strong>pupillary dilation,</strong> its mechanism <strong>(antagonism of cholinergic action) </strong>is<strong> not analogous</strong> to the direct<strong> stimulatory effect of pilocarpine</strong> <strong>on the sphincter pupillae</strong>. <strong>Phenylephrine&#39;s </strong>direct<strong> agonistic</strong> action on the <strong>dilator pupillae </strong>makes it the analogous agent.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylephrine, a sympathomimetic agent,</strong> directly stimulates the <strong>dilator pupillae to cause dilation, </strong>serving as an<strong> analogous action</strong> to <strong>pilocarpine&#39;s</strong> stimulation of the <strong>sphincter pupillae</strong> to cause <strong>constriction. </strong></span></span></p>",
    "correct_choice_id": 13176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3316,
    "choices": [
      {
        "id": 13243,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic receptor antagonist</span></span></span></p>"
      },
      {
        "id": 13244,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor antagonist</span></span></span></p>"
      },
      {
        "id": 13245,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histaminic antagonist</span></span></span></p>"
      },
      {
        "id": 13246,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonergic antagonist</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxybutynin is a drug used for treatment of overactive bladder. It acts as?&nbsp; </span></span></span></p>",
    "unique_key": "Q6204649",
    "question_audio": null,
    "question_video": null,
    "map_id": 35904,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscarinic receptor antagonist</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxybutynin </strong>acts as a <strong>muscarinic receptor antagonist.</strong> It specifically <strong>targets muscarinic receptors </strong>in the <strong>urinary bladder and salivary</strong> <strong>glands</strong>, making it <strong>effective in treating</strong> conditions like <strong>detrusor overactivity</strong>, which causes symptoms such as <strong>urinary frequency and</strong> <strong>urge incontinence.</strong> By <strong>blocking</strong> the <strong>action of acetylcholine</strong> on these receptors, <strong>oxybutynin helps</strong> to <strong>relax the bladder muscle</strong> (<strong>detrusor) and increase bladder capacity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option A.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic receptor antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp; Incorrect </strong>because<strong> oxybutynin does not </strong>primarily act on <strong>adrenergic receptors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Histaminic antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect </strong>as <strong>oxybutynin</strong> <strong>does not</strong> <strong>block histamine receptors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Serotonergic antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect</strong> since <strong>oxybutynin</strong> is<strong> not </strong>known to<strong> antagonize serotonergic receptors</strong> in the context of <strong>overactive bladder treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember that <strong>oxybutynin is a muscarinic receptor antagonist </strong>used in the treatment of <strong>overactive bladder</strong> due to its <strong>selective</strong> <strong>action on M1 and M3 muscarinic subtypes,</strong> which provides <strong>therapeutic benefits</strong> in conditions like<strong> detrusor instability and</strong> <strong>neurogenic bladder.</strong></span></span></span></p>",
    "correct_choice_id": 13244,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3319,
    "choices": [
      {
        "id": 13255,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apraclonidine</span></span></span></p>"
      },
      {
        "id": 13256,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></p>"
      },
      {
        "id": 13257,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost</span></span></span></p>"
      },
      {
        "id": 13258,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs used in treatment of glaucoma is an alpha-2-agonist? </span></span></span></p>",
    "unique_key": "Q3991841",
    "question_audio": null,
    "question_video": null,
    "map_id": 35905,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Apraclonidine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apraclonidine </strong>is an<strong> alpha-2 adrenergic receptor agonist</strong> used in the treatment of <strong>glaucoma.</strong> It works by <strong>reducing the production of</strong> <strong>aqueous humor and increasing its outflow </strong>through the<strong> trabecular meshwork.</strong> By <strong>stimulating alpha-2 receptors, apraclonidine</strong> <strong>decreases</strong> the<strong> synthesis and secretion of aqueous humor,</strong> thereby <strong>lowering intraocular pressure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Timolol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol is a <strong>non-selective beta-adrenergic receptor blocker (beta-blocker)</strong> used in the <strong>treatment</strong> <strong>of glaucoma.</strong> It works by<strong> reducing the production of aqueous humor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Latanoprost:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost is a<strong> prostaglandin analog </strong>used in the <strong>treatment of glaucoma.</strong> It works by <strong>increasing the outflow</strong> of <strong>aqueous humor</strong> through the <strong>uveoscleral pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Netarsudil:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil is a <strong>rho kinase inhibitor </strong>used in the treatment of <strong>glaucoma</strong>. It works by <strong>increasing the outflow of</strong> <strong>aqueous humor</strong> through the <strong>trabecular meshwork and Schlemm&#39;s canal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apraclonidine,</strong> as an <strong>alpha-2 adrenergic receptor agonist,</strong> <strong>reduces intraocular pressure </strong>by<strong> decreasing</strong> the production of <strong>aqueous</strong> <strong>humor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121842.jpg\" style=\"height:315px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3329,
    "choices": [
      {
        "id": 13295,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Carvedilol &ndash; &beta;<sub>2</sub> agonistic activity </span></span></span></p>"
      },
      {
        "id": 13296,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Celiprolol &ndash; Potassium channel blocker </span></span></span></p>"
      },
      {
        "id": 13297,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lebetalol &ndash; Calcium channel blocker</span></span></span></p>"
      },
      {
        "id": 13298,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Nebivolol &ndash; Enhance NO production </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following match of a 3<sup>rd</sup> generation beta blocker with its mechanism of vasodilatory property is correct? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "unique_key": "Q4619082",
    "question_audio": null,
    "question_video": null,
    "map_id": 35887,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Nebivolol: Enhance NO production </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third generation beta blockers are any of the beta blockers (either first generation or second generation) that possess additional vasodilatory property.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol is classified as a <strong>third-generation beta-blocker</strong> because it has additional <strong>vasodilatory effects</strong> due to its ability to<strong> increase</strong> the <strong>production of nitric oxide (NO) </strong>from the <strong>endothelium</strong>, which leads to <strong>vasodilation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carvedilol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>because <strong>carvedilol has alpha-blocking properties </strong>as well as <strong>antioxidant properties</strong> that contribute to its<strong> vasodilatory effects</strong>, <strong>not &beta;2 agonistic activity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Celiprolol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because <strong>celiprolol </strong>has some<strong> &beta;2 agonistic effects</strong> which may contribute to its <strong>vasodilatory properties,</strong> <strong>not potassium channel blocking. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Labetalol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>because l<strong>abetalol blocks both alpha and beta receptors</strong> but <strong>does not act</strong> as a <strong>calcium channel</strong> <strong>blocker.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol&#39;s</strong> mechanism of<strong> vasodilation</strong> is distinct among<strong> beta blockers </strong>because it enhances <strong>nitric oxide production,</strong> leading to <strong>vasodilation without </strong>the <strong>typical resistance </strong>seen with <strong>pure beta-blocking effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of vasodilation in third generation beta blockers </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-165735.jpg\" style=\"height:200px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 13298,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3354,
    "choices": [
      {
        "id": 13395,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of benzalkonium bromide in the preparation</span></span></span></p>"
      },
      {
        "id": 13396,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prejunctional M2 receptor stimulation</span></span></span></p>"
      },
      {
        "id": 13397,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated use of hypertonic saline in nebulizer</span></span></span></p>"
      },
      {
        "id": 13398,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of EDTA as impurity</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can be the mechanism for paradoxical bronchoconstriction seen with the use of ipratropium bromide Except?</span></span></span></p>",
    "unique_key": "Q3513814",
    "question_audio": null,
    "question_video": null,
    "map_id": 35891,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Prejunctional M2 receptor stimulation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prejunctional M2 receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Their activation typically <strong>inhibits the release of acetylcholine,</strong> contributing to <strong>bronchodilation. Ipratropium, </strong>as an <strong>anticholinergic agent</strong>, <strong>would not </strong>stimulate but <strong>block M2 receptors,</strong> potentially leading to<strong> increased release of acetylcholine</strong> and resulting in<strong> bronchoconstriction</strong> in some patients. This mechanism is <strong>not</strong> usually the c<strong>ause of paradoxical bronchoconstriction </strong>observed with <strong>ipratropium,</strong> making it the exception among the options provided.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Benzalkonium bromide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>preservative</strong> in some<strong> inhaler formulation</strong>s, which can cause <strong>airway irritation and</strong> <strong>constriction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypertonic saline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can also cause <strong>bronchoconstriction</strong> due to its <strong>osmotic effects on the airway.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. EDTA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can act as an <strong>irritant </strong>leading to <strong>bronchoconstriction </strong>when included as an <strong>impurity in the formulation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>ipratropium bromide</strong> is typically used for its <strong>bronchodilatory effects, </strong>certain <strong>excipients or impurities </strong>in the formulation, like <strong>benzalkonium bromide or EDTA, </strong>as well as associated use of <strong>hypertonic saline,</strong> can lead to<strong> paradoxical bronchoconstriction.</strong> However,<strong> prejunctional M2 receptor stimulation</strong> would<strong> no</strong>t be the <strong>correct mechanism</strong> for this<strong> adverse effect</strong>, as <strong>ipratropium would</strong> <strong>block </strong>rather than stimulate these receptors.</span></span></span></p>",
    "correct_choice_id": 13396,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3280,
    "choices": [
      {
        "id": 13099,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug A in the graph is epinephrine </span></span></span></p>"
      },
      {
        "id": 13100,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effect on heart rate in graph A can be prevented by anti-muscarinic agents </span></span></span></p>"
      },
      {
        "id": 13101,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug acting on graph B is isoprenaline </span></span></span></p>"
      },
      {
        "id": 13102,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug acting in the graph C is nor-epinephrine </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pharmacological experiment was conducted to study effect of three drugs on heart rate and blood pressure. The following graphs were obtained before and after giving the drug. Which of the following statements is correct? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture11.jpg\" style=\"height:223px; width:300px\" /></p>",
    "unique_key": "Q1351235",
    "question_audio": null,
    "question_video": null,
    "map_id": 35923,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) The effect on heart rate in graph A can be prevented by anti-muscarinic agents </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided shows <strong>three different graphs labelled A, B, and C</strong>, each depicting<strong> changes in systolic blood pressure (SBP), mean</strong> <strong>blood pressure (MBP), diastolic blood pressure (DBP), and heart rate </strong>before and after the administration of a drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effect on heart rate in graph A can be prevented by anti-muscarinic agents:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> correct </strong>because the <strong>reflex bradycardia </strong>seen in response to <strong>increased blood pressure </strong>is mediated by the<strong> parasympathetic nervous system, </strong>which can be <strong>inhibited</strong> by <strong>anti-muscarinic agents</strong>, thereby<strong> preventing the decrease in heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here&#39;s an analysis of each graph:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There&#39;s an <strong>increase in SBP and DBP</strong>, with a marked <strong>increase in MBP</strong>, followed by a<strong> reflex bradycardia (a decrease in heart rate). </strong>This response is consistent with a<strong> drug that causes vasoconstriction</strong>, leading to <strong>increased blood pressure </strong>and a <strong>subsequent reflex slowing of the heart rate </strong>due to<strong> vagal stimulation</strong>. These properties suggest that it is<strong> norepinephrine. </strong>This <strong>reflex decrease </strong>in <strong>heart rate </strong>can be prevented by <strong>anti-muscarinic drugs </strong>like<strong> atropine</strong>. <strong>After giving atropine, same dose of nor-epinephrine </strong>produces <strong>tachycardia </strong>instead of bradycardia because of<strong> its direct action </strong>only. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shows an<strong> increase in SBP and decrease in DBP </strong>with slight <strong>increase in MBP </strong>and a significant <strong>increase in heart rate</strong>. This pattern is typical of<strong> adrenaline</strong>, which has<strong> potent effects on the heart rate</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There&#39;s a <strong>substantial increase in SBP </strong>with significant <strong>fall in DBP and MBP, </strong>and significant <strong>increase in heart rate</strong>. This pattern<strong> suggests </strong>that the<strong> drug </strong>is likely to be<strong> isoprenaline. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Drug A in the graph can be epinephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect </strong>since <strong>epinephrine </strong>usually<strong> increases heart rate </strong>due to its <strong>beta-1</strong> <strong>stimulatory effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option C. The drug acting on graph B is isoprenaline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect </strong>because<strong> isoprenaline (also known as isoproterenol)</strong> is a<strong> non-selective beta-adrenergic agonist </strong>that can<strong> increase SBP</strong> but <strong>decrease DBP </strong>and<strong> MBP.</strong> Rather the graph shown is typically present in epinephrine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The drug acting in graph C is norepinephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong> because <strong>norepinephrine </strong>primarily<strong> increases SBP,</strong> <strong>DBP and MBP </strong>and cause <strong>reflex tachycardia.</strong> The<strong> graph shown </strong>is typically present in<strong> isoprenaline. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-muscarinic agents</strong> can prevent the <strong>reflex bradycardia</strong> induced by <strong>vasoconstrictive drugs </strong>like<strong> norepinephrine </strong>by inhibiting the <strong>parasympathetic nervous system&#39;s</strong> control <strong>over the heart.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Goodman and Gilman 12th/283</span></strong></span></span></p>",
    "correct_choice_id": 13100,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 3353,
    "choices": [
      {
        "id": 13391,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 13392,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol</span></span></span></p>"
      },
      {
        "id": 13393,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></span></p>"
      },
      {
        "id": 13394,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with acute glaucoma and painful red eye. Intraocular pressure was 38 mmHg. Slit lamp examination showed aqueous flare and keratic precipitates. Which of the following drugs should not be given in this patient for the control of glaucoma?</span></span></span></p>",
    "unique_key": "Q1335755",
    "question_audio": null,
    "question_video": null,
    "map_id": 35928,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient given in the question presents with<strong> acute glaucoma a</strong>ccompanied by <strong>uveitis,</strong> as indicated by symptoms like a <strong>painful red</strong> <strong>eye, elevated intraocular pressure (38 mmHg), aqueous flare, and keratic precipitates</strong>.<strong> Uveitis</strong> involves <strong>inflammation of the uveal</strong> <strong>tract of the eye,</strong> which can <strong>complicate</strong> the <strong>management of glaucoma.</strong> The<strong> presence of uveitis</strong> necessitates the <strong>use of medication</strong>s that <strong>lower intraocular pressure</strong> without worsening the<strong> inflammatory component of the disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (D. Prostaglandin analogues) are generally <strong>contraindicated in cases of glaucoma</strong> with <strong>concurrent uveitis.</strong> Prostaglandin analogues can potentially<strong> exacerbate inflammation within the eye. </strong>These drugs are effective in<strong> lowering intraocular pressure </strong>by<strong> increasing uveoscleral outflow</strong> in<strong> chronic open-angle glaucoma </strong>but may <strong>not</strong> be suitable in the <strong>presence of uveiti</strong>s due to their <strong>potential to increase inflammation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Beta blockers</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (A. Beta blockers) <strong>reduce intraocular pressure</strong> by <strong>decreasing </strong>the production of<strong> aqueous humor.</strong> They <strong>do not </strong>directly address <strong>inflammation</strong> but can be used in <strong>conjunction </strong>with <strong>anti-inflammatory treatments.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Mannitol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (B. Mannitol), an <strong>osmotic diuretic</strong>, can <strong>rapidly reduce intraocular pressure</strong> by <strong>drawing fluid out</strong> of the <strong>eye,</strong> including in <strong>acute settings. </strong>It <strong>does not</strong> worsen the <strong>underlying inflammation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (C. Acetazolamide) <strong>reduces aqueous humor production </strong>and, consequently, <strong>ientraocular pressure.</strong> These<strong> does not</strong> worsen<strong> inflammation</strong> and is used as part of a <strong>broader treatment regimen.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>For managing uveitis</strong> specifically,<strong> treatment </strong>often includes <strong>corticosteroids (either topical, periocular, or systemic)</strong> to <strong>reduce</strong> <strong>inflammation and immunosuppressive agent</strong>s in <strong>more severe cases</strong>. It&rsquo;s important to treat <strong>both the inflammation</strong> caused by<strong> uveitis</strong> and the <strong>elevated intraocular pressure to prevent vision loss.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> presence of uveitis </strong>in a patient with<strong> glaucoma </strong>significantly<strong> impacts </strong>the choice of treatment. Understanding the need to <strong>manage</strong> <strong>intraocular pressure </strong>while also addressing<strong> ocular inflammation is crucial.</strong> The goal is to select a treatment regimen that effectively <strong>lowers intraocular pressure without exacerbating uveitis</strong>, highlighting the importance of a comprehensive approach to patient care that considers the complexities introduced by overlapping ocular conditions.</span></span></span></p>",
    "correct_choice_id": 13394,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3352,
    "choices": [
      {
        "id": 13387,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">64-year-old female with frequent attacks of migraine</span></span></span></p>"
      },
      {
        "id": 13388,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors </span></span></p>"
      },
      {
        "id": 13389,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">56-year-old male with erectile dysfunction</span></span></span></p>"
      },
      {
        "id": 13390,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">74-year-old male with history of compensated heart failure</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following patients would not benefit from the use of beta blockers? </span></span></p>",
    "unique_key": "Q2391640",
    "question_audio": null,
    "question_video": null,
    "map_id": 35927,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 56-year-old male with erectile dysfunction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are a <strong>class of medications </strong>that can be used for <strong>various conditions</strong>, including <strong>migraine prophylaxis</strong>, <strong>management of</strong> <strong>hyperthyroid symptoms, and heart failure. </strong>However, they can have <strong>side effects</strong> that <strong>affect sexual function</strong>, making them <strong>potentially</strong> <strong>problematic</strong> for patients <strong>with erectile dysfunction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. 64-year-old female with frequent attacks of migraine:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are often used for the<strong> prophylaxis of</strong> <strong>migraines</strong>. They can help <strong>reduce the frequency </strong>and <strong>severity of migraine attacks.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are <strong>useful </strong>in managing symptoms of <strong>hyperthyroidism </strong>such as <strong>tachycardia and tremors </strong>by <strong>blocking the effects</strong> of <strong>excess</strong> t<strong>hyroid hormones on the heart and other tissues.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 74-year-old male with history of compensated heart failure:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Certain&nbsp;<strong>beta-blockers </strong>are indicated in the management of <strong>heart failure</strong>. They can i<strong>mprove survival and reduce</strong> the need for<strong> hospitalization</strong> in patients with <strong>heart</strong> <strong>failure, </strong>especially those with a<strong> history of compensated heart failure, </strong>provided they are <strong>carefully selected and dosed.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>indications and contraindications </strong>for <strong>beta-blocker therapy</strong>. While<strong> beta-blockers are versatile</strong> <strong>medications </strong>with a <strong>broad range of clinical applications</strong>, their<strong> potential side effects, </strong>such as <strong>exacerbating erectile dysfunction</strong>, must be considered when <strong>prescribing these drugs to ensure they align </strong>with the patient&#39;s overall <strong>health status and medical needs.</strong></span></span></p>",
    "correct_choice_id": 13389,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3295,
    "choices": [
      {
        "id": 13159,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      },
      {
        "id": 13160,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagon</span></span></span></p>"
      },
      {
        "id": 13161,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
      },
      {
        "id": 13162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nor-adrenaline</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child opened his father&rsquo;s drawer and ingested multiple tablets of his cardiac medication, metoprolol. The child was brought to hospital with profound hypotension and bradycardia. What is the specific antidote used in this situation?</span></span></span></p>",
    "unique_key": "Q5316725",
    "question_audio": null,
    "question_video": null,
    "map_id": 35930,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Glucagon</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The case described is <strong>indicative of beta-blocker poisoning </strong>due to the <strong>ingestion of metoprolol. Glucagon</strong> is the <strong>specific antidote </strong>for <strong>beta-blocker toxicity.&nbsp;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Metoprolol </strong>is a <strong>beta-blocker </strong>that <strong>slows down </strong>the <strong>heart rate </strong>and <strong>reduces the strength of the heart&#39;s contractions</strong>. In an <strong>overdose</strong>, it can cause <strong>bradycardia and hypotension</strong>. Normally<strong> beta-blockers</strong> work by <strong>blocking beta-adrenergic</strong> <strong>receptors</strong> on heart cells. These<strong> receptors </strong>usually <strong>respond to adrenaline </strong>and similar substances to<strong> increase heart rate </strong>and <strong>strength</strong>.&nbsp;In an <strong>overdose, </strong>the <strong>heart can&#39;t </strong>respond to <strong>adrenaline </strong>because the<strong> beta-blockers </strong>are blocking the <strong>receptors </strong>too much. This makes it hard to use medications like <strong>adrenaline or dobutamine effectively</strong>.&nbsp;<strong>Glucagon</strong> <strong>bypasses</strong> the <strong>blocked receptors</strong>. Instead of working through the<strong> beta-adrenergic receptors</strong>, it<strong> stimulates glucagon receptors </strong>in heart and <strong>increases cyclic AMP (cAMP). </strong>Latter&nbsp;helps the heart cells to <strong>increase their rate and strength of</strong> <strong>contraction</strong>. This means the heart can <strong>beat faster </strong>and <strong>pump blood</strong> more effectively, even when <strong>beta-blockers </strong>are <strong>blocking </strong>the usual pathways. Thus,by <strong>increasing cAMP</strong>, <strong>glucagon </strong>helps <strong>counteract </strong>the effects of the <strong>beta-blocker overdose</strong>, <strong>improving heart rate </strong>and <strong>blood pressure</strong>, and stabilizing the patient&#39;s condition.</span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\">In summary,<strong> glucagon </strong>works as <strong>an antidote</strong> for<strong> beta-blocker overdose </strong>by <strong>increasing cAMP </strong>in heart cells, which <strong>helps</strong> <strong>the heart beat faster and stronger</strong>, even when the <strong>usual beta-adrenergic receptors </strong>are <strong>blocked </strong>by the <strong>overdose.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment for Beta-Blocker Poisoning:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucagon </strong>is used due to its ability to <strong>stimulate cardiac activity </strong>without relying on<strong> beta-adrenergic receptors</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>may be <strong>administered </strong>if there is <strong>severe bradycardia, and a pacemaker </strong>may be necessary.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium gluconate </strong>can also be <strong>beneficial </strong>in treating <strong>beta-blocker poisoning.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of<strong> hypotension</strong>, <strong>large doses of isoproterenol </strong>or an alpha receptor agonist may be required.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<h2 style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options</strong></span></h2>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Dobutamine:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dobutamine is a <strong>beta-1 adrenergic agonist</strong> that can <strong>increase heart rate and contractility.</strong> While it can be used to support cardiac function, it is <strong>not the specific antidote for beta-blocker overdose.</strong> Its effectiveness may also be reduced due to the beta-blockade.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.&nbsp; Adrenaline:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Adrenaline (epinephrine) is a <strong>non-selective adrenergic agonist </strong>that can <strong>increase heart rate and blood pressure.</strong> It can be used in <strong>severe cases of beta-blocker overdose, </strong>but it is<strong> not the specific antidote.</strong> Its use may be limited by the <strong>beta-blockade</strong>, and it can have significant side effects.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Nor-adrenaline:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Nor-adrenaline (norepinephrine) is primarily an<strong> alpha-adrenergic agonist </strong>with <strong>some beta-adrenergic effects</strong>. It is used to <strong>increase blood pressure </strong>through <strong>vasoconstriction.</strong> However, it is <strong>not the specific antidote</strong> for <strong>beta-blocker</strong> <strong>overdose</strong> and may not adequately address bradycardia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In cases of <strong>beta-blocker overdose</strong>, such as with <strong>metoprolol</strong>, the specific antidote is<strong> glucagon</strong>. It works by <strong>increasing</strong> <strong>cyclic AMP independently </strong>of the <strong>beta-adrenergic receptors</strong>, thereby <strong>improving heart rate and contractility </strong>despite the<strong> beta-blockade. </strong>Understanding the <strong>role of glucagon </strong>and its mechanism of action is crucial in <strong>managing beta-blocker toxicity effectively</strong>.</span></span></p>",
    "correct_choice_id": 13160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3285,
    "choices": [
      {
        "id": 13119,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a quaternary ammonium compound</span></span></span></p>"
      },
      {
        "id": 13120,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is metabolized by liver</span></span></span></p>"
      },
      {
        "id": 13121,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can cross the blood brain barrier</span></span></span></p>"
      },
      {
        "id": 13122,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has no direct agonistic action on N<sub>M</sub> receptors</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True statements about neostigmine are?</span></span></span></p>",
    "unique_key": "Q4056490",
    "question_audio": null,
    "question_video": null,
    "map_id": 35925,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It is a quarternary ammonium compound </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine </strong>is a <strong>quaternary ammonium compound</strong>. This <strong>chemical </strong>structure is significant because <strong>quaternary ammonium </strong>compounds are<strong> water soluble</strong> and this<strong> imparts</strong> certain pharmacological properties to neostigmine, such as its <strong>inability to easily cross</strong> <strong>lipid membranes</strong>, including the <strong>blood-brain barrier.</strong> This characteristic influences <strong>its distribution and the site of action,</strong> mainly <strong>restricting </strong>it to the <strong>peripheral nervous system</strong>. <strong>Neostigmine </strong>works primarily by <strong>inhibiting acetylcholinesterase</strong>, the enzyme responsible for <strong>breaking down acetylcholine</strong> in the <strong>neuromuscular junction.</strong> This inhibition <strong>leads to an increase in acetylcholine</strong> <strong>concentration at the neuromuscular junction,</strong> thereby enhancing<strong> cholinergic transmission,</strong> which can <strong>stimulate muscle contraction.</strong> Its action is thus primarily indirect as it<strong> increases the action of acetylcholine.</strong> However,<strong> neostigmine and pyridostigmine (unlike</strong> <strong>physostigmine) </strong>have been found to have some <strong>direct agonist action</strong> on &nbsp;<strong>neuromuscular (NM) receptor</strong>s also.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation of other options:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B</strong>. <strong>It is metabolized by liver:&nbsp;Neostigmine</strong> is primarily <strong>hydrolysed by cholinesterases</strong> in the plasma and, to a lesser extent, in the liver. Its metabolism is <strong>not predominantly hepatic, </strong>which is a common misconception. The role of the liver in its metabolism is limited compared to the <strong>hydrolysis happening in the plasma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C</strong>. <strong>It can cross the blood brain barrier:</strong> As a <strong>quaternary ammonium compound, neostigmine</strong> is <strong>charged and polar, </strong>making it <strong>poorly lipid-soluble.</strong> This property significantly<strong> limits its ability to cross the blood-brain barrier.</strong> Therefore, <strong>neostigmine </strong>has<strong> minimal</strong> c<strong>entral nervous system effects</strong> under normal therapeutic conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D</strong>. <strong>It has no direct agonistic action on NM receptors:</strong> This statement is <strong>not completely true.</strong> Neostigmine works primarily by <strong>inhibiting acetylcholinesterase,</strong> the enzyme responsible for <strong>breaking down acetylcholine </strong>in the neuromuscular junction. This inhibition leads to an <strong>increase in acetylcholine concentration </strong>at the<strong> neuromuscular junction,</strong> thereby enhancing <strong>cholinergic</strong> <strong>transmission</strong>, which can stimulate <strong>muscle contraction. </strong>Its action is thus primarily <strong>indirect</strong> as it<strong> increases the action of acetylcholine.</strong> However, <strong>neostigmine and pyridostigmine (unlike physostigmine) </strong>have been found to have some <strong>direct agonist action</strong> on &nbsp;<strong>neuromuscular (NM) receptors </strong>also.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em>Neostigmine</em> </strong>is a <strong>quaternary ammonium </strong>compound that <strong>inhibits acetylcholinesterase, </strong>thereby <strong>increasing acetylcholine levels </strong>at the<strong> neuromuscular junction </strong>and enhancing <strong>cholinergic transmission</strong>. <strong>Neostigmine </strong>also act as<strong> direct agonist of Nm receptors </strong>and has <strong>limited ability </strong>to <strong>cross the blood-brain barrier </strong>due to its<strong> quaternary ammonium structure</strong>. Its <strong>metabolism </strong>mainly involves <strong>hydrolysis by cholinesterase </strong>rather than liver metabolism.</span></span></p>",
    "correct_choice_id": 13119,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3305,
    "choices": [
      {
        "id": 13199,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an agonist at &alpha;<sub>1A</sub> adrenergic receptors</span></span></span></p>"
      },
      {
        "id": 13200,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used to produce sedation in critically ill patients</span></span></span></p>"
      },
      {
        "id": 13201,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used as an adjunct in anesthesia</span></span></span></p>"
      },
      {
        "id": 13202,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Its route of administration is intravenous</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements are True about Dexmedetomidine except?<span style=\"color:black\"> </span></span></span></p>",
    "unique_key": "Q6111281",
    "question_audio": null,
    "question_video": null,
    "map_id": 35916,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It is an agonist at &alpha;<sub>1A</sub> adrenergic receptors</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Dexmedetomidine</strong> is a highly selective <strong>&alpha;2A adrenergic receptor agonist </strong>and not an &alpha;1A adrenergic receptor agonist. This specificity for the <strong>&alpha;2A receptor subtype </strong>is responsible for its <strong>sedative and anxiolytic effects </strong>without causing significant<strong> respiratory depression</strong>. It is used to provide<strong> sedation in various clinical settings</strong>, including <strong>critical care </strong>and as an <strong>adjunct to anesthesia </strong>due to these properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>It is used to produce sedation in critically ill patients:</strong>&nbsp; This is <strong>correct as dexmedetomidine </strong>is commonly used in the<strong> ICU setting </strong>for its sedative properties with<strong> minimal respiratory depression</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>It is used as an adjunct in anesthesia:</strong>&nbsp; <strong>This is true</strong>;<strong> dexmedetomidine</strong> is used as <strong>an adjunct </strong>due to its <strong>sedative, anxiolytic, and analgesic properties</strong>, making it a versatile drug in anesthetic practice. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Its route of administration is intravenous:</strong>&nbsp;This is <strong>correct; dexmedetomidine </strong>is typically administered <strong>intravenously</strong>, especially in a <strong>hospital setting</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> essential fact </strong>to remember about <strong>dexmedetomidine </strong>is that it is a <strong>selective &alpha;2A adrenergic receptor agonist</strong>, not &alpha;1A, and is used <strong>intravenously </strong>to <strong>sedate critically ill </strong>patients and as an <strong>adjunct in anesthesia</strong>, with the benefit of causing <strong>minimal respiratory depression.</strong></span></span></span></p>",
    "correct_choice_id": 13199,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3307,
    "choices": [
      {
        "id": 13207,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baygon</span></span></p>"
      },
      {
        "id": 13208,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tik 20</span></span></p>"
      },
      {
        "id": 13209,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathion</span></span></p>"
      },
      {
        "id": 13210,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endrin</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine is indicated in all the following poisonings except<strong>?</strong></span></span></p>",
    "unique_key": "Q8011747",
    "question_audio": null,
    "question_video": null,
    "map_id": 35918,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">And. D) Endrin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine, </strong>a <strong>muscarinic antagonist, </strong>is the treatment of choice for poisonings by <strong>acetylcholinesterase inhibitors</strong>, which include <strong>organophosphates and carbamates.</strong> These substances lead to the <strong>accumulation of acetylcholine at the synapses,</strong> causing <strong>overstimulation of muscarinic and nicotinic receptors</strong>. Atropine works by <strong>blocking the muscarinic effects </strong>of this <strong>excess acetylcholine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Baygon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Contains <strong>carbaryl, </strong>a carbamate <strong>insecticide. Atropine </strong>is used to <strong>treat poisoning </strong>due to its mechanism as an <strong>acetylcholinesterase inhibitor. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tik 20:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contains <strong>diazinon</strong>, an <strong>organophosphate insecticide. Atropine</strong> is also<strong> indicated </strong>for the same reason as Baygon. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Parathion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;An <strong>organophosphate compound </strong>and <strong>atropine is indicated</strong> for its poisoning due to its <strong>acetylcholinesterase</strong> <strong>inhibitory action.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>is <strong>not indicated</strong> for <strong>poisoning by Endrin,</strong> an<strong> organochlorine insecticide,</strong> because it<strong> does not inhibit acetylcholinesterase </strong>like the other compounds listed. While <strong>atropine is effective </strong>for <strong>organophosphate and carbamate poisoning</strong>, <strong>organochlorine poisonings do not</strong> have a <strong>specific antidote</strong> and are treated <strong>supportively.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 7th/105</span></span></strong></p>",
    "correct_choice_id": 13210,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3324,
    "choices": [
      {
        "id": 13275,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase heart rate</span></span></span></p>"
      },
      {
        "id": 13276,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease total peripheral resistance</span></span></span></p>"
      },
      {
        "id": 13277,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease pupil size</span></span></span></p>"
      },
      {
        "id": 13278,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has no effect on cardiovascular system?</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous administration of norepinephrine in a patient already taking an effective dose of atropine will often?</span></span></span></p>",
    "unique_key": "Q9720923",
    "question_audio": null,
    "question_video": null,
    "map_id": 35929,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Increase heart rate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Intravenous administration of nor-adrenaline</strong> to a normal person result in<strong> bradycardia.</strong> This effect is due to mainly indirect <strong>effect on</strong> <strong>heart:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By directly<strong> stimulating beta 1 receptors in heart</strong>, <strong>NA</strong> tend to cause <strong>tachycardia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>increase in blood pressure,</strong> there is <strong>reflex activation of parasympathetic system</strong>. This <strong>stimulates M2 receptors</strong> in heart resulting in <strong>bradycardia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reflex </strong>action is <strong>stronger</strong> as compared to<strong> direct effect</strong>, therefore <strong>net effect</strong> in a<strong> normal person is bradycardia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, <strong>if a person</strong> is already <strong>taking atropine,</strong> this <strong>indirect effect</strong> <strong>cannot</strong> appear because <strong>atropine blocks M2</strong> <strong>receptors.</strong> Therefore, only<strong> direct effect comes </strong>which result in<strong> tachycardia.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decrease total peripheral resistance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Norepinephrine typically<strong> increases total peripheral resistance</strong> due to its <strong>potent</strong> <strong>vasoconstrictive </strong>effects on <strong>alpha-1 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decrease pupil size:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine</strong> primarily acts on<strong> alpha-adrenergic receptors</strong>, leading to<strong> pupillary dilation (mydriasis),</strong> rather than constriction.<strong> Atropine</strong>, being a<strong> muscarinic receptor antagonist, </strong>also causes<strong> pupillary dilation</strong>. Therefore, the <strong>combined effect of norepinephrine and atropine</strong> would likely <strong>maintain</strong> or <strong>increase pupil size.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Has no effect on the cardiovascular system:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine</strong> has significant effects on the <strong>cardiovascular system,</strong> including <strong>increasing blood pressure, heart rate, and cardiac contractility,</strong> primarily through its actions on <strong>alpha and beta adrenergic</strong> <strong>receptors</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;In this scenario, the <strong>combined administration of norepinephrine (which has beta-1 adrenergic activity) and atropine (a muscarinic</strong> <strong>receptor antagonist)</strong> results in an<strong> increased heart rate</strong> due to the <strong>unopposed action of norepinephrine</strong> on <strong>beta-1 adrenergic</strong> <strong>receptors</strong> in the<strong> heart. </strong></span></span></span></p>",
    "correct_choice_id": 13275,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3327,
    "choices": [
      {
        "id": 13287,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brimonidine decreases aqueous production</span></span></span></p>"
      },
      {
        "id": 13288,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost is a carbonic anhydrase inhibitor</span></span></span></p>"
      },
      {
        "id": 13289,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine increases uveoscleral outflow</span></span></span></p>"
      },
      {
        "id": 13290,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol increases trabecular outflow</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Correct match of drug and mechanism of action is:</span></span></span></p>",
    "unique_key": "Q9919001",
    "question_audio": null,
    "question_video": null,
    "map_id": 35914,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Brimonidine decreases aqueous production.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Brimonidine</strong> is an<strong> alpha-2 adrenergic agonist</strong> that primarily <strong>decreases aqueous humor production </strong>by inhibiting the <strong>release</strong> of <strong>norepinephrine</strong>, leading to <strong>reduced activity of adenylate cyclase</strong> in the <strong>ciliary body.</strong> It also acts partly by <strong>increasing uveoscleral outflow</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Latanoprost is a carbonic anhydrase inhibitor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Latanoprost is a&nbsp;<strong> prostaglandin analog</strong> that<strong> increases the outflow of</strong> <strong>aqueous humor </strong>through the <strong>uveoscleral pathway</strong> by <strong>relaxing the ciliary muscle</strong> and <strong>expanding</strong> the spaces in the <strong>trabecular</strong> <strong>meshwork.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pilocarpine increases uveoscleral outflow:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pilocarpine is a <strong>muscarinic receptor agonist</strong> that primarily works by <strong>contracting</strong> the <strong>ciliary muscle</strong>, leading to <strong>widening of the spaces between the muscle bundles </strong>and <strong>increasing trabecular outflow, </strong>rather than uveoscleral outflow.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Betaxolol increases trabecular outflow:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Betaxolol is a<strong> beta-blocker </strong>used in the<strong> treatment of glaucoma. </strong>It works by <strong>reducing intraocular pressure </strong>through a mechanism involving the <strong>reduction of aqueous humor production </strong>by the <strong>ciliary body.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122831.jpg\" style=\"height:248px; width:1000px\" /></span></u></strong></span></span></p>",
    "correct_choice_id": 13287,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3336,
    "choices": [
      {
        "id": 13323,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salivation</span></span></span></p>"
      },
      {
        "id": 13324,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mydriasis</span></span></span></p>"
      },
      {
        "id": 13325,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vomiting</span></span></span></p>"
      },
      {
        "id": 13326,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are findings of cholinergic toxidrome except? </span></span></span></p>",
    "unique_key": "Q2652352",
    "question_audio": null,
    "question_video": null,
    "map_id": 35915,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Mydriasis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic toxidrome </strong>refers to the <strong>cluster of symptoms</strong> associated with<strong> overstimulation of cholinergic receptors, </strong>typically due to the <strong>excessive accumulation of acetylcholine at neuromuscular junctions</strong> <strong>and synapses</strong> due to <strong>inhibitors </strong>of the enzyme <strong>acetylcholinesterase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mydriasis, or pupil dilation,</strong> is <strong>not</strong> typical of <strong>cholinergic toxidrome.</strong> Instead,<strong> miosis, or pinpoint pupils, </strong>is<strong> expected</strong> due to the <strong>overstimulation of muscarinic receptors in the eye</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Salivation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Increased </strong>salivation is a <strong>hallmark of cholinergic toxidrome</strong> due to <strong>stimulation of muscarinic receptors (M3). </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vomiting:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Another<strong> classic feature</strong> due to the a<strong>ctivation of the digestive system&#39;s muscarinic pathways. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bradycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Stimulation of muscarinic receptors (M2) </strong>in the heart <strong>slows the heart rate</strong>, leading to <strong>bradycardia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In cholinergic toxidrome</strong>, <strong>expect pinpoint pupils (miosis),</strong> not dilated pupils (mydriasis), along with <strong>excessive secretion </strong>such as <strong>salivation, sweating, lacrimation, symptoms of gastrointestinal upset</strong> like <strong>vomiting, and bradycardia.</strong> Mydriasis is typically associated with <strong>anticholinergic toxidrome, not cholinergic.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms of cholinergic overdose include:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/30.jpg\" style=\"height:1090px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 13324,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3337,
    "choices": [
      {
        "id": 13327,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benign hyperplasia of prostate</span></span></span></p>"
      },
      {
        "id": 13328,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angle closure glaucoma</span></span></span></p>"
      },
      {
        "id": 13329,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AV block</span></span></span></p>"
      },
      {
        "id": 13330,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are contraindications to the use of atropine except? </span></span></span></p>",
    "unique_key": "Q7869508",
    "question_audio": null,
    "question_video": null,
    "map_id": 35917,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) AV block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine,</strong> an<strong> antimuscarinic agent,</strong> is <strong>not contraindicated </strong>in the case of <strong>AV (atrioventricular) block;</strong> in fact, it is often <strong>used as drug of</strong> <strong>choice </strong>for treatment of patients with <strong>AV block and bradycardia. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Benign hyperplasia of prostate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Atropine</strong> can cause <strong>urinary retention, </strong>which is why it is <strong>contraindicated in</strong> patients with <strong>benign prostatic hyperplasia (BPH).</strong> A<strong>tropine&#39;s antimuscarinic effects reduce bladder muscle contraction,</strong> <strong>exacerbating t</strong>he difficulty in<strong> urination</strong> caused by <strong>prostate enlargement.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Angle closure glaucoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Atropine is contraindicated</strong> in patients with <strong>angle closure glaucoma </strong>because it can <strong>increase intraocular pressure</strong>. Its <strong>antimuscarinic action dilates the pupil (mydriasis),</strong> which can <strong>block the drainage of</strong> <strong>aqueous humor </strong>through the <strong>trabecular meshwork, </strong>worsening the condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Paralytic ileus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Atropine is contraindicated</strong> in patients with<strong> paralytic ileus</strong> because its <strong>antimuscarinic effects</strong> can<strong> inhibit gastrointestinal motility, exacerbating </strong>the condition by further <strong>slowing or stopping the movement </strong>of the <strong>intestines.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to <strong>identify the contraindications of atropine</strong> use, focusing on its<strong> antimuscarinic effects</strong> on <strong>various organ systems.</strong> Here is a table listing the <strong>contraindications of atropine </strong>along with explanations for each:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/40.jpg\" style=\"height:487px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 13329,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3338,
    "choices": [
      {
        "id": 13331,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 1</span></span></span></p>"
      },
      {
        "id": 13332,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 2</span></span></span></p>"
      },
      {
        "id": 13333,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 1</span></span></span></p>"
      },
      {
        "id": 13334,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old female with an unremarkable past medical history presents with fever, sore throat, and a tender cervical lymphadenopathy. She is diagnosed with streptococcal Group A pharyngitis and is treated with IM penicillin. Within a few minutes of the injection, the patient is dyspneic, tachycardic, and hypotensive, and is noted to have wheezing on examination. She also complains of dysphagia. IM epinephrine is administered immediately. Which adrenoceptor primarily mediates the respiratory system response? </span></span></p>",
    "unique_key": "Q4364272",
    "question_audio": null,
    "question_video": null,
    "map_id": 35919,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Beta 2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient probably developed <strong>anaphylactic shock due to penicillin.</strong> <strong>Adrenaline</strong> is <strong>drug of choice</strong> for<strong> anaphylactic shock</strong>. The <strong>primary adrenoceptor</strong> that mediates the<strong> respiratory system response, </strong>especially in the context of treating anaphylaxis with<strong> IM</strong> <strong>epinephrine</strong> as described in the scenario, is the<strong> Beta 2 adrenoceptor.</strong> Beta 2 adrenoceptors are <strong>predominantly found </strong>in the <strong>smooth</strong> <strong>muscles of the bronchi</strong> and are responsible for <strong>mediating bronchodilation</strong> when<strong> stimulated.</strong> In a case of <strong>anaphylaxis,</strong> where there is <strong>bronchoconstriction </strong>leading to symptoms like<strong> wheezing and dyspnea</strong>, administration of <strong>epinephrine acts primarily on Beta 2</strong> <strong>adrenoceptors to cause bronchodilation,</strong> thus<strong> alleviating </strong>these <strong>respiratory symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha 1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Alpha 1 adrenoceptors </strong>primarily mediate <strong>vasoconstriction</strong> and are involved in <strong>increasing peripheral</strong> <strong>vascular resistance</strong>, which can help in <strong>raising blood pressure</strong>. They are <strong>not directly </strong>involved in the mediation of the <strong>respiratory system&#39;s response</strong> to <strong>epinephrine</strong> in<strong> anaphylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alpha 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Alpha 2 adrenoceptors </strong>are mainly involved in the<strong> feedback</strong> inhibition of<strong> norepinephrine release</strong> and <strong>do not </strong>play a direct role in the <strong>acute management of anaphylaxis </strong>or in mediating <strong>respiratory system</strong> responses such as <strong>bronchodilation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Beta 1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Beta 1 adrenoceptors</strong> are primarily found in the<strong> heart,</strong> where they <strong>increase heart rate </strong>and <strong>myocardial</strong> <strong>contractility. </strong>While beneficial in <strong>anaphylaxis for supporting cardiac output, </strong>they <strong>do not</strong> directly mediate the <strong>respiratory</strong> <strong>system&#39;s response to epinephrine.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>pharmacological effects of adrenoceptors,</strong> specifically the role of <strong>Beta 2 adrenoceptors </strong>in <strong>mediating bronchodilation </strong>in the context of <strong>anaphylaxis treatment. </strong>Recognizing the<strong> target receptors</strong> of emergency medications like <strong>epinephrine is crucial </strong>for effective clinical management of <strong>acute allergic reactions and anaphylaxis</strong>, <strong>ensuring prompt</strong> and appropriate<strong> intervention </strong>to <strong>alleviate life-threatening symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/111.jpg\" style=\"height:391px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13334,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3341,
    "choices": [
      {
        "id": 13343,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine</span></span></span></p>"
      },
      {
        "id": 13344,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></span></p>"
      },
      {
        "id": 13345,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrochlorothiazide</span></span></span></p>"
      },
      {
        "id": 13346,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents to your office for a regular check-up. Her only complaint is recurrent migraine headaches, which have increased in frequency over the years. On examination, her blood pressure is elevated at 150/70. Which of the following drug is an antihypertensive also and can be used prophylaxis of migraine? </span></span></span></p>",
    "unique_key": "Q8340819",
    "question_audio": null,
    "question_video": null,
    "map_id": 35920,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Propranolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the patient has two issues:<strong> elevated blood pressure and recurrent migraine headaches.</strong> <strong>Propranolol is a beta-blocker</strong> that is used<strong> both as an antihypertensive agent</strong> and for the <strong>prophylaxis of migraines.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> non-selective beta-adrenergic receptor blocker</strong> that <strong>reduces heart rate, blood pressure, </strong>and the <strong>intensity/frequency of migraine attacks.</strong> Its efficacy in <strong>migraine prophylaxis </strong>is <strong>well-documented</strong>, making it a suitable <strong>choice for patients</strong> who experience <strong>migraines and have hypertension.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clonidine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Clonidine is a<strong> centrally acting alpha-2 adrenergic agonist</strong> that<strong> lowers blood pressure </strong>by <strong>decreasing</strong> <strong>sympathetic outflow </strong>from the<strong> central nervous system</strong>. While it is effective for<strong> hypertension,</strong> it is <strong>not </strong>commonly <strong>used for</strong> <strong>migraine prophylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Prazosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Prazosin is an <strong>alpha-1 adrenergic receptor blocker</strong> used primarily for treating <strong>hypertension </strong>and symptoms of<strong> benign prostatic hyperplasia. </strong>It is <strong>not</strong> indicated for the<strong> prophylaxis of migraines.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hydrochlorothiazide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hydrochlorothiazide is a<strong> thiazide diuretic </strong>used to <strong>treat hypertension</strong> by <strong>removing</strong> <strong>excess fluid </strong>from the body. It is<strong> not </strong>used for <strong>migraine prophylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the<strong> dual use of certain antihypertensive medications,</strong> such as <strong>propranolol, </strong>in managing<strong> both</strong> <strong>elevated blood pressure</strong> and providing <strong>prophylactic treatment for migraine headaches.</strong> This case <strong>highlights</strong> the importance of <strong>selecting medications </strong>that can address <strong>multiple patient concerns simultaneously,</strong> thereby<strong> optimizing therapeutic outcomes.</strong></span></span></span></p>",
    "correct_choice_id": 13346,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 3342,
    "choices": [
      {
        "id": 13347,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></span></p>"
      },
      {
        "id": 13348,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
      },
      {
        "id": 13349,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></span></p>"
      },
      {
        "id": 13350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female patient started on a new antihypertensive medication recently. Her blood pressure seems to be under control, but she complains of fatigue, drowsiness, and fainting when she gets up from the bed. Which of the following drugs is she most likely taking?</span></span></p>",
    "unique_key": "Q5381405",
    "question_audio": null,
    "question_video": null,
    "map_id": 35921,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Prazosin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>symptoms </strong>described by the patient, including fatigue, <strong>drowsiness, and fainting</strong> upon <strong>standing (orthostatic hypotension), </strong>suggest she is experiencing<strong> side effects</strong> that are commonly associated with <strong>alpha-1 adrenergic receptor blockers</strong> like <strong>Prazosin.</strong> Prazosin is used to <strong>treat hypertension </strong>and works by<strong> relaxing blood vessels </strong>so that<strong> blood can flow more easily,</strong> but it can <strong>cause</strong> <strong>orthostatic hypotension </strong>as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Metoprolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Metoprolol is a<strong> beta-1 selective adrenergic receptor blocker (beta-blocker)</strong> used to treat <strong>high</strong> <strong>blood pressure, heart pain (angina), and prevent heart attacks</strong>. While it can cause <strong>fatigue, </strong>it is <strong>less </strong>commonly associated with the severity of <strong>orthostatic hypotension</strong> described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Propranolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Propranolol is a <strong>non-selective beta-adrenergic receptor blocke</strong>r that can treat <strong>high blood</strong> <strong>pressure, irregular heartbeats, </strong>and other conditions.<strong> Similar to metoprolol, </strong>while it might cause <strong>drowsiness or fatigue,</strong> <strong>pronounced orthostatic hypotension </strong>is <strong>not as characteristic </strong>as with <strong>alpha blockers.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Clonidine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Clonidine is an <strong>alpha-2 adrenergic agonist</strong> that<strong> lowers blood pressure </strong>by <strong>decreasing the amoun</strong>t of <strong>certain chemicals </strong>in your blood. This allows your<strong> blood vessels to relax</strong> and your<strong> heart to beat more slowly and easily.</strong> It can cause<strong> drowsiness, </strong>but the specific symptoms of<strong> orthostatic hypotension </strong>upon standing are <strong>more closely</strong> associated with<strong> alpha-1 blockers like Prazosin.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to identify the a<strong>ntihypertensive medication</strong> most likely to <strong>cause orthostatic hypotension</strong> among the options provided. <strong>Understanding </strong>the <strong>side effect</strong> profiles of <strong>antihypertensive agents,</strong> especially those that can <strong>impact patient safety and</strong> <strong>quality of life</strong>, such as <strong>orthostatic hypotension,</strong> is crucial in<strong> managing and monitoring treatment in hypertensive patients.</strong></span></span></span></p>",
    "correct_choice_id": 13349,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3343,
    "choices": [
      {
        "id": 13351,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is contraindicated in hypertrophic cardiomyopathy</span></span></p>"
      },
      {
        "id": 13352,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be given topically for treatment of glaucoma</span></span></span></p>"
      },
      {
        "id": 13353,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a lipid soluble non-selective beta blocker</span></span></p>"
      },
      {
        "id": 13354,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It inhibits the release of T3 and T4 and is therefore useful in hyperthyroidism.</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding propranolol, find out the true statement? </span></span></span></p>",
    "unique_key": "Q5867630",
    "question_audio": null,
    "question_video": null,
    "map_id": 35922,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It is a lipid soluble non-selective beta blocker.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol is a <strong>non-selective beta-adrenergic receptor blocker</strong>, meaning it blocks both <strong>beta-1 and beta-2 adrenergic</strong> <strong>receptors.</strong> Its<strong> lipid solubility</strong> allows it to <strong>cross the blood-brain barrier</strong>, which contributes to its <strong>central nervous system</strong> <strong>effects.</strong> This property makes <strong>propranolol effective</strong> for a variety of <strong>uses,</strong> including <strong>anxiety, migraine prophylaxis and</strong> <strong>akathisia</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is contraindicated in hypertrophic cardiomyopathy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>false</strong>. <strong>Propranolol </strong>is actually <strong>drug of</strong> choice in the management of <strong>hypertrophic cardiomyopathy</strong> to help<strong> control heart rate and reduce left ventricular</strong> <strong>outflow obstruction</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It can be given topically for treatment of glaucoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect </strong>regarding<strong> propranolol. Beta-blockers </strong>like <strong>timolol,</strong> <strong>not propranolol</strong>, are used <strong>topically</strong> in the treatment of <strong>glaucoma</strong> to <strong>reduce intraocular pressure.</strong> Due to its <strong>membrane stabilizing property</strong>, <strong>propranolol is contra-indicated in glaucoma.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It inhibits the release of T3 and T4 and is therefore useful in hyperthyroidism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Propranolol <strong>does not</strong> directly <strong>inhibit</strong> the release of<strong> thyroid hormones (T3 and T4).</strong> However, it is useful in the <strong>symptomatic management of</strong> <strong>hyperthyroidism,</strong> such as <strong>controlling heart rate and tremors</strong>. Its usefulness in h<strong>yperthyroidism</strong> is due to <strong>its beta-blocking effects</strong> rather than a direct effect on thyroid hormone release. It can also<strong> inhibit peripheral conversion of T4 to</strong> <strong>T3.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to clarify the <strong>properties </strong>and<strong> clinical</strong> applications of<strong> propranolol,</strong> a <strong>non-selective beta-blocker </strong>with <strong>lipid</strong> <strong>solubility, </strong>and to <strong>correct misconceptions</strong> regarding its <strong>use and mechanisms of action. </strong>Understanding the pharmacological characteristics and therapeutic implications of <strong>beta-blockers like propranolol </strong>is essential for their appropriate clinical use.</span></span></span></p>",
    "correct_choice_id": 13353,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3345,
    "choices": [
      {
        "id": 13359,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia and AV Block</span></span></span></p>"
      },
      {
        "id": 13360,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia </span></span></span></p>"
      },
      {
        "id": 13361,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsades&rsquo; de pointes </span></span></span></p>"
      },
      {
        "id": 13362,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular tachycardia </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who is on metoprolol for hypertension is given verapamil. What side effect is he likely to suffer from?<strong> </strong></span></span></p>",
    "unique_key": "Q3582231",
    "question_audio": null,
    "question_video": null,
    "map_id": 35924,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bradycardia and AV Block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metoprolol blocks beta-1 adrenergic receptors</strong> in the <strong>heart, </strong>which can<strong> reduce heart rate </strong>and <strong>decrease the strength of cardiac</strong> <strong>muscle contraction.</strong> <strong>Verapamil inhibits calcium channels </strong>in the <strong>heart </strong>that are necessary for<strong> electrical conduction and muscle</strong> <strong>contraction</strong>. Together, these <strong>two drugs</strong> can excessively<strong> suppress cardiac activity,</strong> potentially causing<strong> bradycardia and AV block.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachycardia:</strong> <strong>Unlikely</strong>, since<strong> both drugs have a depressive effect on the heart. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Torsades&rsquo; de pointes:</strong> This is a <strong>specific form of ventricular tachycardia </strong>typically associated with drugs that prolong the<strong> QT</strong> <strong>interval, </strong>which is <strong>not a known effect of either verapamil or metoprolol. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ventricular tachycardia:&nbsp;</strong>This is <strong>not </strong>typically caused by the<strong> combination of a beta-blocker and a calcium channel blocker</strong> like <strong>verapamil</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Combining</strong> <strong>metoprolol with verapamil</strong> can <strong>lead</strong> to an a<strong>dditive effect on the heart,</strong> potentially causing<strong> bradycardia and AV block.</strong> Therefore, such a <strong>combination </strong>should be used with<strong> caution or avoided.</strong></span></span></span></p>",
    "correct_choice_id": 13359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3349,
    "choices": [
      {
        "id": 13375,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A,B,C are correct</span></span></span></p>"
      },
      {
        "id": 13376,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and C are correct</span></span></span></p>"
      },
      {
        "id": 13377,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and D are correct</span></span></span></p>"
      },
      {
        "id": 13378,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All 4 are correct</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the 3<sup>rd</sup> generation beta blockers among the following drugs?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisoprolol</span></span></span></li>\r\n</ol>",
    "unique_key": "Q4081448",
    "question_audio": null,
    "question_video": null,
    "map_id": 35926,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) A, B, C are correct</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<pre>\r\nAny beta blocker whether it is non-selective (first generation) or cardioselective (second generation) that cause vasodilation is called third generation beta blocker. So, all third generation beta blockers will be either first generation or second generation.</pre>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bisoprolol </strong>is a<strong> second-generation beta-blocker</strong> with <strong>selective beta-1 blocking properties. It does not cause vasodilation so it cannot be classified as third generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A<strong> non-selective beta-blocker</strong> with additional <strong>alpha-1 blocking properties,</strong> leading to <strong>vasodilation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Another<strong> non-selective beta-blocker</strong> with <strong>alpha-1 blockade.</strong> It also has <strong>calcium channel blocking and</strong> <strong>antioxidant properties.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>selective beta-1 blocker </strong>with <strong>additional vasodilatory effects</strong> due to <strong>nitric oxide (NO) release.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Labetalol, carvedilol, and nebivolol</strong> are<strong> third-generation beta-blockers </strong>with <strong>additional vasodilatory properties.</strong> This classification is important for the <strong>tailored</strong> <strong>treatment of hypertension, heart failure, and other cardiovascular conditions,</strong> where the<strong> additional</strong> <strong>effects </strong>of these drugs on <strong>vasodilation </strong>can provide<strong> therapeutic advantages.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanations</u>:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/44.jpg\" style=\"height:337px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 13375,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3322,
    "choices": [
      {
        "id": 13267,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13268,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></span></span></p>"
      },
      {
        "id": 13269,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclopentolate</span></span></span></p>"
      },
      {
        "id": 13270,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homatropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the shortest acting mydriatic drug? </span></span></span></p>",
    "unique_key": "Q5666385",
    "question_audio": null,
    "question_video": null,
    "map_id": 35913,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tropicamide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide is an <strong>anticholinergic agent </strong>used as a<strong> mydriatic and cycloplegic drug </strong>for eye examinations. It has the <strong>fastest onset</strong> and the<strong> shortest duration of action </strong>compared to the other options, making it the <strong>shortest acting mydriatic.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because <strong>atropine has a very long duration of action</strong> in the eye, ranging from <strong>7-14 days. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cyclopentolate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as it has a<strong> slower onset of action</strong> and a<strong> longer duration</strong> than <strong>tropicamide. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Homatropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because it <strong>does not </strong>act as<strong> rapidly as tropicamide</strong> and has a <strong>longer duration of action.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tropicamide</strong> is the preferred <strong>mydriatic agen</strong>t for fundus examination due to its<strong> short acting duration</strong>, which is generally around <strong>4-6</strong> <strong>hours</strong>. It is especially <strong>useful over other anticholinergic agents</strong> when a <strong>quick return to normal pupil size</strong> is desired, such as in <strong>outpatient settings.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122143.jpg\" style=\"height:257px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13268,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3626,
    "choices": [
      {
        "id": 14483,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyrotoxicosis</span></span></span></p>"
      },
      {
        "id": 14484,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Variant angina</span></span></span></p>"
      },
      {
        "id": 14485,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine</span></span></span></p>"
      },
      {
        "id": 14486,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol can be used in all of the following conditions except.</span></span></span></p>",
    "unique_key": "Q7024934",
    "question_audio": null,
    "question_video": null,
    "map_id": 35908,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Variant angina&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated in variant angina (Prinzmetal&#39;s angina) </strong>because it is a<strong> non-selective beta-blocke</strong>r that can <strong>exacerbate</strong> <strong>symptoms. Variant angina </strong>is caused by <strong>coronary artery spasms,</strong> and<strong> beta-blockers </strong>like <strong>propranolol </strong>can<strong> increase the risk</strong> of these <strong>spasms</strong> by leaving <strong>unopposed alpha-mediated vasoconstriction</strong>, potentially worsening the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thyrotoxicosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used in <strong>thyrotoxicosis</strong> to provide <strong>symptomatic relief</strong> from<strong> hyperthyroid symptoms </strong>such as <strong>tachycardia, anxiety, and tremors</strong>. It can also <strong>inhibit peripheral conversion of T4 to T3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Migraine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used as a<strong> prophylactic treatment for migraine</strong>. It helps <strong>reduce the frequency </strong>and <strong>severity of</strong> <strong>migraine attacks.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>can be used in the management of <strong>hypertension</strong>. It <strong>lowers blood pressure</strong> by <strong>reducing cardiac</strong> <strong>output</strong> and <strong>inhibiting</strong> <strong>renin</strong> release from the<strong> kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>therapeutic uses </strong>and <strong>contraindications of propranolol,</strong> a <strong>non-selective beta-blocke</strong>r. Recognizing that <strong>propranolol is contraindicated in variant angina </strong>due to its <strong>potential to worsen coronary artery spasms </strong>highlights the importance of considering the specific clinical context when selecting beta-blockers for treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications of &beta;-Blockers:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/88.jpg\" style=\"height:439px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 14484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 3279,
    "choices": [
      {
        "id": 13095,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial fibrillation </span></span></span></p>"
      },
      {
        "id": 13096,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia with AV block </span></span></span></p>"
      },
      {
        "id": 13097,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsades&rsquo; de pointes </span></span></span></p>"
      },
      {
        "id": 13098,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with a history of hypertension has been managing his condition with metoprolol, a beta-blocker, to control his heart rate and blood pressure. Despite this treatment, his blood pressure remains above the target range. His physician decides to add verapamil, a calcium channel blocker, to his regimen to further control his blood pressure. Shortly after initiating verapamil, the patient reports symptoms of fatigue and dizziness. What complication can result from the addition of verapamil to a patient already on metoprolol treatment?</span></span></span></p>",
    "unique_key": "Q1641926",
    "question_audio": null,
    "question_video": null,
    "map_id": 35909,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bradycardia with AV block.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Both metoprolol and verapamil </strong>have <strong>negative chronotropic effects</strong>, meaning they <strong>decrease heart rate</strong>. <strong>Metoprolol </strong>does this by <strong>blocking beta-1 adrenergic receptors</strong>, primarily affecting the <strong>sinoatrial (SA) node</strong>, while <strong>verapamil blocks L-type calcium channels</strong>, which are critical for<strong> impulse conduction </strong>through the<strong> atrioventricular (AV) node.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adding verapamil </strong>to a patient already on <strong>metoprolol increases the risk </strong>of additive effects on <strong>heart rate and conduction</strong>. This can lead to <strong>bradycardia</strong>, which is an <strong>abnormally slow heart rate</strong>, and in <strong>more severe cases</strong>, can progress to<strong> AV block</strong>. AV block occurs when the <strong>electrical conduction between the atria and ventricles is impaired</strong>, potentially leading to <strong>serious heart rhythm abnormalities </strong>and symptoms such as<strong> dizziness and fatigue.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Atrial fibrillation:</strong> is<strong> not </strong>the most likely outcome of<strong> adding verapamil to metoprolol therapy, </strong>although <strong>verapamil is</strong> sometimes used to<strong> control ventricular rate i</strong>n patients <strong>with atrial fibrillation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C. Torsades&rsquo; de pointes:</strong> are a specific type of<strong> ventricular tachycardia </strong>often associated with a <strong>prolonged QT interval,</strong> which is <strong>not </strong>a typical <strong>side effect of either metoprolol or verapamil.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D. Tachycardia: </strong>&nbsp;or<strong> increased heart rate</strong>, would be unlikely as<strong> both drugs </strong>work to <strong>slow the heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the most appropriate answer in the context of this clinical scenario is b. <strong>Bradycardia with AV block</strong>, considering the pharmacological actions of<strong> both metoprolol and verapamil </strong>and the symptoms reported by the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When combining<strong> metoprolol</strong>, a <strong>beta-blocker, with verapamil, a calcium channel blocker,</strong> there is a significant <strong>risk of developing</strong> <strong>bradycardia with AV block</strong> due to their<strong> combined effect </strong>on <strong>slowing heart rate and impairing AV nodal conduction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8th/160</span></strong></span></span></p>",
    "correct_choice_id": 13096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 3315,
    "choices": [
      {
        "id": 13239,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyoscine</span></span></span></p>"
      },
      {
        "id": 13240,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
      },
      {
        "id": 13241,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propantheline</span></span></span></p>"
      },
      {
        "id": 13242,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug is used for treatment of organophosphate poisoning? </span></span></p>",
    "unique_key": "Q4932707",
    "question_audio": null,
    "question_video": null,
    "map_id": 35910,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Atropine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>is an <strong>antimuscarinic agent </strong>that is used as an <strong>antidote</strong> in <strong>organophosphate poisoning</strong>. It counteracts the effects of <strong>excess</strong> acetylcholine due to <strong>anticholinesterase activity at muscarinic receptors</strong> but <strong>does not reactivate the cholinesterase enzyme inhibited by organophosphates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hyoscine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This drug is an <strong>antimuscarinic</strong>, similar to<strong> atropine</strong>, but is <strong>not</strong> typically used for <strong>organophosphate poisoning. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Physostigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This is a <strong>cholinesterase inhibit</strong>or and would worsen <strong>organophosphate poisoning. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Propantheline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; An <strong>antimuscarinic </strong>used for <strong>other indications, not </strong>typically for <strong>organophosphate poisoning.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For <strong>organophosphate poisoning,</strong> <strong>atropine</strong> is the <strong>specific antidote </strong>used to <strong>reverse the muscarinic symptoms</strong> such as <strong>excessive</strong> <strong>salivation, lacrimation, bradycardia, and hypotension </strong>due to the<strong> increased cholinergic activity.</strong></span></span></span></p>",
    "correct_choice_id": 13242,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3328,
    "choices": [
      {
        "id": 13291,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13292,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
      },
      {
        "id": 13293,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scopolamine</span></span></span></p>"
      },
      {
        "id": 13294,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyoscine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a tertiary amine derivative?</span></span></span></p>",
    "unique_key": "Q1204165",
    "question_audio": null,
    "question_video": null,
    "map_id": 35907,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;B) Glycopyrrolate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate </strong>is <strong>not a tertiary amine;</strong> it is a <strong>quaternary ammonium compound. Tertiary amines</strong> have the ability to<strong> cross the blood-brain barrier </strong>due to their structure, whereas <strong>quaternary ammonium compounds</strong>, such <strong>as glycopyrrolate</strong>, are<strong> unable to cross </strong>due to their <strong>charged nature.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, as it is a<strong> tertiary amine</strong> and <strong>can cross the blood-brain barrier,</strong> leading to <strong>central effects. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Scopolamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect,</strong> as it is a <strong>tertiary amine</strong> with <strong>central effects</strong> and is also known as <strong>hyoscine. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hyoscine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect, </strong>as it is <strong>another name for scopolamine</strong>, a<strong> tertiary amine </strong>with<strong> central actions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate</strong> is a <strong>quaternary ammonium compound,</strong> which <strong>cannot cross the blood-brain barrier,</strong> distinguishing it from <strong>tertiary</strong> <strong>amines </strong>like <strong>atropine and scopolamine (also known as hyoscine),</strong> which can have <strong>central nervous system effects.</strong></span></span></span></p>",
    "correct_choice_id": 13292,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3348,
    "choices": [
      {
        "id": 13371,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></p>"
      },
      {
        "id": 13372,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></p>"
      },
      {
        "id": 13373,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></p>"
      },
      {
        "id": 13374,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tremors</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are adverse effects of salmeterol except? </span></span></span></p>",
    "unique_key": "Q3784326",
    "question_audio": null,
    "question_video": null,
    "map_id": 35911,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Hypoglycemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salmeterol </strong>is a <strong>beta 2 agonist.</strong> It can result in <strong>tachycardia, tremors and hypokalemia</strong> but <strong>not hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 agonists</strong> like <strong>salmeterol</strong> can lead to <strong>hypokalemia</strong> due to <strong>intracellular shifting of potassium.</strong> They can also cause<strong> tremors </strong>due to <strong>stimulation of beta-2 receptors in the skeletal muscles</strong> and <strong>tachycardia</strong> by affecting the <strong>heart.</strong> However, they<strong> do not</strong> typically cause<strong> hypoglycemia</strong>, which is <strong>more </strong>commonly associated with <strong>insulin </strong>or other <strong>glucose-lowering medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypokalemia:</strong> Can occur <strong>due to the intracellular shifting of potassium ions. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachycardia:</strong> Can result from<strong> beta-2 stimulation in the heart</strong>, leading to<strong> increased heart rate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors:</strong> Are a common side effect <strong>due to stimulation of beta-2 receptors</strong> in the <strong>skeletal muscles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salmeterol,</strong> as a <strong>beta-2 agonist,</strong> <strong>does not</strong> typically cause <strong>hypoglycemia;</strong> its adverse effects related to <strong>beta-2 stimulation</strong> include <strong>tremors, tachycardia, and hypokalemia. </strong>Always monitor these potential side effects when prescribing or using beta-2 agonists.</span></span></p>",
    "correct_choice_id": 13371,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 3350,
    "choices": [
      {
        "id": 13379,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bethanechol</span></span></p>"
      },
      {
        "id": 13380,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsolusin</span></span></p>"
      },
      {
        "id": 13381,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin</span></span></p>"
      },
      {
        "id": 13382,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methacholine</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with diabetes and COPD developed postoperative urinary retention. Which of the following drugs can be used for short-term treatment to relieve the symptoms of this person?</span></span></span></p>",
    "unique_key": "Q6062291",
    "question_audio": null,
    "question_video": null,
    "map_id": 35912,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bethanechol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of <strong>postoperative urinary retention, </strong>we must consider the<strong> drug</strong> that can effectively<strong> stimulate bladder emptying</strong> <strong>without</strong> exacerbating the<strong> patient&#39;s COPD. </strong></span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given drugs,<strong> only bethanechol</strong> is useful for treatment of<strong> post operative urinary</strong> <strong>retention</strong>. <strong>Though</strong> it<strong> can worsen COPD </strong>by causing<strong> bronchoconstriction </strong>but still this<strong> should be the answer,</strong> as no other drug given in options is <strong>useful in post operative retention.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation of options:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bethanechol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>drug</strong> is indeed used to<strong> treat urinary retention</strong>, as it <strong>stimulates muscarinic receptors</strong> in the<strong> bladder to</strong> <strong>induce contraction.</strong> Given that it is a <strong>direct cholinergic agonist, </strong>it could cause <strong>bronchoconstriction </strong>and <strong>would not</strong> be <strong>ideal </strong>for a patient with <strong>COPD, </strong>but it remains a treatment option specifically for<strong> urinary retention if the COPD </strong>is <strong>well-controlled and not severe.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tamsulosin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this drug is<strong> primarily used </strong>in the context of<strong> BPH, </strong>it <strong>does no</strong>t have a direct action to <strong>stimulate bladder</strong> <strong>emptying </strong>in the <strong>absence of BPH</strong> and is<strong> not used for postoperative urinary retention.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Terazosin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Similar to tamsulosin, terazosin </strong>is an <strong>alpha-blocker </strong>used in<strong> BPH</strong> and is <strong>not used for postoperative urinary</strong> <strong>retention </strong>unless there is <strong>concurrent BPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Methacholine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is <strong>primarily used for diagnostic purposes </strong>in conditions like<strong> asthma </strong>and is<strong> not used for treating</strong> <strong>urinary retention. </strong>Like<strong> bethanechol, </strong>it could potentially <strong>exacerbate COPD</strong> due to<strong> bronchoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bethanechol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the <strong>drug</strong> that is used for <strong>non-BPH</strong> related <strong>urinary retention, </strong>as it directly <strong>stimulates the detrusor muscle of the</strong> <strong>bladder</strong>. However, it would need to be<strong> used with caution </strong>in a patient with <strong>COPD. </strong>We need to <strong>weigh the benefits</strong> of using <strong>bethanechol for urinary retention </strong>against the risk of <strong>exacerbating the patient&#39;s COPD </strong>and<strong> monitor the patient closely.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given drugs,<strong> only bethanechol </strong>is useful for treatment of<strong> post operative urinary retention.</strong> Though it can <strong>worsen</strong> <strong>COPD by causing bronchoconstriction </strong>but still this should be the answer, as<strong> no other drug given in option</strong>s is useful in <strong>post operative retention.</strong></span></span></p>",
    "correct_choice_id": 13379,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 3287,
    "choices": [
      {
        "id": 13127,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13128,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimercaprol</span></span></span></p>"
      },
      {
        "id": 13129,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
      },
      {
        "id": 13130,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pralidoxime</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old farm worker is rushed to a nearby emergency department after an accidental exposure to parathion. Which of the following drugs can be given to increase the activity of his acetyl cholinesterase?</span></span></span></p>",
    "unique_key": "Q7314033",
    "question_audio": null,
    "question_video": null,
    "map_id": 35886,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pralidoxime</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pralidoxime</strong> is a drug used in the treatment of <strong>organophosphate poisoning,</strong> such as that caused by exposure to <strong>parathion.</strong> <strong>Organophosphates</strong> inhibit <strong>acetylcholinesterase</strong>, leading to an <strong>accumulation of acetylcholine</strong> at<strong> synapses and neuromuscular</strong> <strong>junctions,</strong> which results in <strong>cholinergic crisis </strong>symptoms. <strong>Pralidoxime</strong> works by<strong> reactivating acetylcholinesterase </strong>that has been <strong>inhibited by organophosphates</strong>, thereby <strong>restoring its activity and alleviating the symptoms of poisoning</strong>. It is <strong>most effective</strong> when <strong>administered as soon as possible after exposure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A.</strong> <strong>Atropine:</strong> <strong>Atropine</strong> is <strong>drug of choice </strong>as an <strong>antidote in organophosphate poisoning</strong>, but it <strong>does not increase</strong> the activity of <strong>acetylcholinesterase. </strong>Instead, it<strong> serves to counteract the effects </strong>of excess<strong> acetylcholine on muscarinic receptors</strong>, thereby relieving symptoms such as<strong> bradycardia, salivation, and bronchoconstriction. Atropine does not </strong>affect the <strong>nicotinic receptor-mediated</strong> <strong>effects (e.g., muscle weakness, paralysis).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dimercaprol:</strong> Dimercaprol is a chelating <strong>agent </strong>used in the treatment of <strong>poisoning by heavy metals</strong>, such as <strong>arsenic, lead, and mercury</strong>. It is <strong>not </strong>used in the treatment of <strong>organophosphate poisoning </strong>and <strong>does not </strong>i<strong>ncrease acetylcholinesterase activity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Physostigmine:</strong> Physostigmine is a <strong>cholinesterase inhibitor, </strong>and<strong> unlike pralidoxime, </strong>it would exacerbate the effects of <strong>organophosphate poisoning</strong> by further<strong> inhibiting acetylcholinesterase. </strong>Therefore, it is <strong>not used</strong> in the treatment of <strong>organophosphate poisoning </strong>and is <strong>contraindicated in such cases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pralidoxime</strong> is used to<strong> reactivate acetylcholinesterase</strong> inhibited by organophosphates, thereby r<strong>educing the toxic accumulation of</strong> <strong>acetylcholine</strong>. This treatment, often used in <strong>conjunction with atropine to manage muscarinic symptoms,</strong> is critical in the management of <strong>organophosphate poisoning,</strong> highlighting the importance of <strong>specific antidotes in toxicological emergencies.</strong></span></span></span></p>",
    "correct_choice_id": 13130,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  }
];
        let quizName = 'Autonomic Nervous System';
        const quizFilename = 'autonomic-nervous-system-74fc7a7e.html';
        let hierarchy = ["Cerebellum", "qBank", "Pharmacology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>